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Fasting and ketogenic diet prevent seizures in epileptic children, magnesium-
deficient rats and other animal models of seizure disorders. This effect has been attributed 
to increased levels of circulating ketone bodies. The purpose of this study was to 
determine the role of serum ketone bodies, measured as beta-hydroxybutyrate (BHB), in 
preventing audiogenically-induced seizures in weanling rats fed a magnesium-deficient diet 
for 17 days. 
The effect on seizure susceptibility was investigated by feeding a magnesium-
deficient diet to weanling rats for 17 days. Fasting and ketogenic diet (dietary medium 
chain triglycerides, MCT) markedly decreased seizure incidence that was associated with 
increased serum BHB level. Also, rats fasted for 24h or fed 28 percent dietary MCT had 
decreased seizure incidence as compared with rats fed 3 percent dietary MCT or rats fasted 
for 6h. These effects were not caused by differences in caloric density or percentage of 
calories from fat in the diets. 
Gavaging 2 mmoles of BHB resulted in lower seizure incidence; as compared with 
rats gavaged with 0.5 mmoles BHB when measured 30 min after dosing. In contrast, 
gavaging 5.6 mmoles of glucose resulted in increased seizure incidence in 24-h-fasted rats. 
Gavaging 5.6 mmoles of glucose with 0.5 mmole of BHB simultaneously resulted 
in higher seizure incidence than gavaging with 2.0 mmole BHB and 1.4 mmole glucose 
xvi 
simultaneuosly. In addition, gavaging 5.6 mmoles of glucose with 2 mmoles of BHB 
resulted in higher seizure incidence than gavaging 2 mmoles of BHB alone, which 
markedly reduced seizure incidence in fasted animals. 
• 
Fasting, ketogenic diet (MCT) and gavaging BHB increase serum BHB and 
decrease serum glucose concentrations . Gavaging glucose reduced serum BHB and 
increased serum glucose concentration. There was an inverse relationship between serum 
BHB and glucose in all treatments of this study. Although some treatments affected serum 
minerals, these effects were not consistent among experiments. Therefore, fasting, 
ketogenic diet (MCT) and gavaging BHB or glucose does not affect serum minerals 
markedly or consistently; and modifications in serum minerals caused by these treatments 
do not account for this effect on seizure incidence and severity. Finally, increases in serum 
BHB and decreases in serum glucose were consistently associated with dose-dependent 




Generalized epilepsy is a disease of the central nervous system characterized by a 
massive neuronal discharge followed by tetanic muscle contraction; paralleled with an 
increase of cerebral blood flow and metabolism and followed by a loss of consciousness 
that may last for only a few seconds, as in petit mal attacks, or may be accompanied by 
convulsions, as in grand mal attacks. It occurs more frequently in children than in adults 
(Robinson, 1972). Epilepsy affects about 2.5 million Americans and is second only to 
stroke as the leading neurological disorder (Porter et al., 1985), with an incidence of 0.3-
7 .0/1000 among men and women of all ages (Anonymous, 1957). There are 20-40 million 
epileptic people worldwide (Delgado-Escueta et al., 1986). 
There are three types of minor motor seizures: (1) Akinetic seizures are 
characterized by a sudden, momentary loss of muscle tone. This may be partial, in which 
case the attack consists of a sudden dropping forward of the head and neck, known as the 
"saluum seizure" (Menkes, 1976). (2) The term myoclonic seizures describes a variety of 
convulsive episodes characterized by single or repetitive contractures of a muscle or a 
group of muscles. Myoclonic seizures may be isolated, as in benign essential myoclonus, 
-~ 
a condition in which evidence for other neurological abnormalities is lacking, or may occur 
in association with other seizure forms (Grosz-Selbeck and Doose, 1975). (3) Atypical 
petit mal seizures, unlike those of true petit mal, have a tendency to occur in cycles and to 
disappear for periods of time up to several days (Menkes, 197 6). 
Audiogenic seizures are convulsions triggered by exposure to intense auditory 
stimulation; these seizures have been known in rats and mice since 1924 (Krushinsky et 
al., 1970). Although uncommon in man (Bickford and Klass, 1968), they can be 
experimentally induced in house mice (Vicari, 1951), deer mice (Watson, 1939), rats 
(Maier and Glaser, 1940) and rabbits (Nellhause, 1958). The age of an animal 
2 
significantly influences the audiogenic seizure susceptibility; young animals are more 
susceptible to audiogenic seizures than old animals (Vicari, 1951). Later, it was discovered 
that auditory exposure or audiogenic priming induces audiogenic seizures (Iturrian and 
Fink, 1968). Genetic factors and biochemical mechanisms, such as deficiencies in A TPase 
activities, alterations in neurotransmitter metabolism and differences in endocrine function, 
have been found responsible for audiogenic seizure susceptibility (Seyfried, 1979). 
There are three principal reasons why investigation of induced convulsions is of 
value: (1) The appearance of seizures may be influenced by a number of factors; such as 
conflict, electrical stimulation, injection with certain drugs and deprivation of any of several 
dietary elements. The pattern of behavior might be employed as an assay indicator of the 
presence and strength of such factors. (2) Convulsions may alter other behavioral and 
physiological characteristics of the organisms, e.g., changes in brain metabolism and 
neurotransmitter concentrations, diurnal activity, physiological condition and general 
activity . (3) The nature of the convulsion is of considerable interest for its own sake. Its 
outward resemblance to human epileptic convulsions has frequently been pointed out. 
Even if nothing can be contributed to the understanding of these human syndromes, at least 
the controlled observation of the rat seizure will expand our knowledge of basic 
neurophysiological processes. 
The first progress in the study of convulsive disorders began with classification of 
the causes of convulsions in children. This made possible the diagnosis of epilepsy. The 
next advance was made in the study of the metabolic changes that precipitate convulsions in 
the potentially epileptic child. The beneficial effects of fasting and purging have been 
known since antiquity, but their mechanism has never been satisfactorily established . The 
favorable effect of dietary ketosis has been well-studied and effectively demonstrated 
(Peterman, 1946). It is well known that a ketogenic diet decreases seizures in epileptic 
individuals (Huttenlocher et al., 1971; Mike, 1965; Wilder, 1921 ). 
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Induction and characteristics 
Several factors can cause susceptibility to audiogenic seizure: conflict, electrical 
stimulation, drugs and deficiency of some dietary nutrients such as vitamin B6, vitamin D, 
magnesium and calcium (Smolen et al., 1982). Many sound-generating systems, such as 
electric door bells and high-frequency sounds, can induce audiogenic seizures in mice 
(Dice, 1935). Sound between 90 and 120 decibels at frequencies between 10-20 KHZ is 
most effective for inducing audiogenic seizures (Alexander and Alexander, 1976; 
Schreiber, 1977). 
Audiogenic seizures are characterized by the onset of an explosive burst of wild 
running, which develops into a clonic seizure where the rat falls onto its side. After that, 
the tonic seizure appears as all four legs are rigid and extended to the rear. Death will occur 
unless the animal is resuscitated by a relaxation of the pinnae (Buck et al., 1978). Seizures 
can be given a score based on the severity of the animal's response to the sound: 0= no 
seizure, 1= wild running, 2= clonic seizure and 3= tonic seizure (Schreiber and 
Schlesinger, 1972). Death is scored higher than tonic seizure (Willott and Henry, 1976). 
Buck et al. (1978) used the following scoring system for magnesium-deficient rats: 0= no 
seizure, 1= rapid running, 2= clonic, characterized by full body convulsions but with the 
animal usually on its feet, 3= tonic flexion, characterized by the animal on its side, rigid 
andkicking, 4= tonic extension, characterized by rigidity and extended legs and 5= lethal 
seizure. 
Biochemical studies 
Although there is a considerable evidence of biochemical differences invQlved with 
the manifestation of audiogenic seizures, the underlying mechanism responsible for 
audiogenic seizures has not been conclusively reported. Rosenblatt et al. (1976) and 
Davies and Peterson (1989) found that cation (Ca+2, Mg+2, K+, and Na+) imbalance 
induced convulsive disorders. The (Na+,K+)-ATPase activity was decreased in the brains 
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of audiogenic seizure-susceptible mouse strains (Fromby, 1975). Coleman (1960) found a 
positive relationship between audiogenic disorder and the deficiency of phenylalanine 
hydroxy lase; decreasing the activity of this enzyme decreased the levels of serotonin and 
norepinephrine and enhanced seizure susceptibility. Schlesinger et al. (1975) also 
observed that a decreased concentration of brain serotonin and norepinephrine was 
associated with the induction of audiogenic seizures in genetically susceptible mice. 
Epilepsy is a disease of cell excitability. The intracellular concentrations of Na+ and 
K+ ions are important in regulating cell-membrane excitability in nerve, muscle and 
secretory cells. A direct correlation between brain excitability and intracellular Na+ ion has 
been known since 1955 (Woodbury, 1955). The inward current of Na+ ions is 
overpowered by the outward current of K+ ions. Seizures cause an exchange of Na+ for 
K+ in the brain-cells (Woodbury, 1955). The (Na+,K+)-ATPase enzyme is responsible 
for maintaining the inward sodium electrochemical gradient across cell membranes 
(Flatman, 1984), the resting potential of the all cell membranes. The (Na+,K+)-ATPase is 
activated by Na+ on the inside and by K+ on the outside of the cell; consequently, 
insufficient activation of both glycolysis and cell-membrane ATPase by K+ leads to 
seizures (Viukari, 1970). The three biochemical defects found in epileptic tissue are low 
potassium, acetylcholine and glutamate levels. Therefore, any defect of the (Na+,K+)-
A TPase enzyme system leads to seizure susceptibility (Viukari, 1970). 
It is now generally thought that many hormonal effects are mediated through the 
activation of membrane (Na+,K+)-ATPase (Robinson, 1972). In the central nervous 
system, (Na+,K+)-ATPase is known to be concentrated in synaptic membranes (Coan and 
Collingridge, 1985) where neurohormones are also found. Yoshimura (1973) showed that 
catecholamine (epinephrine, dopamine or serotonin) increases brain (Na+,K+)-A TPase 
activity, which transforms ATP to cyclic AMP; then c-AMP as well as potassium, 
promotes glycolysis; which activates phosphofructokinase. Low K+ levels have been 
5 
found in epileptic individuals; therefore, insufficient activation of both (Na+,K+)-ATPase 
and glycolysis may play a part in epilepsy (Viukari, 1970). 
Norepinephrine and serotonin play important roles in the regulation of seizures. 
Neurotransmitter abnormalities have been implicated as the cause of seizure susceptibility in 
rats and humans (Jobe and Laird, 1981 ). Neurotransmitter defects associated with 
cholinergic, catecholaminoergic, serotonergic and amino-acid systems have also been 
reported in humans with epilepsy (Jobe and Laird, 1981). Jobe and Laird (1981) showed 
that an increase in norepinephrine levels had a marked anticonvulsant action; whereas 
elevation of dopamine did not. Ko et al. (1982) and Shaywitz et al. (1978) reported that 
some drugs increased brain norepinephrine and dopamine content; which was associated 
with reduced seizure intensity. Pharmacologic studies showed that elevation of 
catecholamine levels, especially dopamine, lower seizure intensity and susceptibility (Jobe 
and Laird, 1981 ). In contrast, reduction in brain serotonin by p-chlorophenylalanine 
caused an inhibition of audiogenic seizure in mice (Alexander and Kopeloff, 1977). 
Coleman ( 1960) found a positive relationship between audiogenic seizures and 
deficient phenylalanine hydroxylase activity; a decrease in this enzyme could enhance 
seizure activity by lowering the concentration of the neurotransmitters serotonin and 
norepinephrine. Schlesinger et al. (1975) found a genetic relationship between decreased 
levels of serotonin and norepinephrine and increased seizure susceptibility in mice. 
Other studies showed that taurine, gama-aminobutyric acid (GABA), glycine and 
aminoisobutyric acid cause a dose-dependent reduction in audiogenic seizure activity in 
genetically epilepsy-prone rats (Jobe and Laird, 1981; Laird et al., 1984 ). Laird and 
Huxtable (1976) found that injection of taurine directly into the coliculi (auditory nuclei) 
increased seizures in genetically epilepsy-prone rats but not in normal rats. Bonhaus et al. 
(1982) also found that taurine, with pyridoxine deficiency, induced seizures in rats; which 
they attributed to increased brain glutamate decarboxylase activity. Harriman (1988) 
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reported that seizure attacks in magnesium-deficiency states resembled those occurring in 
pyridoxine-deficiency. 
Thus, there are many animal models of seizure disorder (Buck et al., 1978; 
Burnham, 1985; Chutkow, 1974; Fisher, 1989; Gaito, 1976), but until recently, 
magnesium-deficiency has received very little attention as a causative agent. However, it is 
unique as a metabolic model in that seizure susceptibility is completely eliminated by 
magnesium therapy (Anderson et al., 1986; Buck et al., 1978; Harriman, 1988; Jones and 
Heinemann, 1988; Leaver et al., 1987). 
Objectives 
The purpose of this study was to investigate the mechanism of fasting and 
ketogenic diet on reducing audiogenic seizure susceptibility of magnesium-deficient rats. 
The study design included the use of acute oral doses of B-hydroxybutyrate (BHB), a 
ketone body and/or glucose, and varying the level of dietary medium-chain triglycerides, a 
ketogenic semi-synthetic fat, to determine their effect on serum BHB and glucose levels 





Magnesium is the fourth most abundant cation in the human body, exceeded only 
by potassium, sodium and calcium in extracellular fluid and by potassium in intracellular 
fluid (Agarwal and Agarwal, 1976; Rude and Singer, 1981; Wacker and Parisi, 1968). 
Magnesium is one of the most vital elements in the body and is involved in numerous 
biochemical reactions, activating about 300 enzymes involving cAMP, ATP and ADP. 
Moreover, alkaline phosphatase is an activator of alkaline phosphatase, acid phosphatase, 
A TPases and phosphatase (Aikawa, 1976; Pedemonte and Beauge, 1986). Magnesium 
plays a role in all ATP-requiring reactions and in stabilization of the structure of DNA, 
RN A and the ribosomal translation in gene expression (Aikawa, 197 6). A lack of 
magnesium inhibits at least seven enzymatic reactions essential to the glycolytic pathway 
for carbohydrate metabolism (Aikawa, 1973). Magnesium is involved in the regulation of 
cellular permeability and neuromuscular excitability (Ebel and Gunther, 1980). 
Magnesium is important in the sodium-dependent ADP-ATP exchange catalyzed by 
(Na+, K+)-A TPase; as well as for the overall hydrolysis of ATP in the presence of Na+ and 
K+ (Ghijsen et al., 1984; Pedemonte and Beauge, 1986). It has been suggested that the 
enzyme (Na+, K+)-A TPase increase in magnesium-deficient rats may reflect cellular action 
to increase excitability (due to the deficiency) by increasing activity of this enzyme (Buck et 
al., 1980). Also, (Na+, K+)-A TPase activity increases in experimental brain injury (Lim 
and Jacob, 1972), hypoxia (Stastny et al., 1971), electric shock and injection with 
pentylenetetrazol (Bignami et al., 1966). All of these lead to seizure susceptibility. In 
contrast, decreased (Na+, K+)-ATPase activity has been noted in uremia (Minkoff et al., 
1972); which inhibits excitability. In addition, magnesium inhibits the release of the 
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brain synaptosomal fractions (Madeira and Antunes-Madeira, 1973; Rodrigues et al., 
1988). 
Distribution of magnesium in the organisms 
Magnesium is the fourth most abundant cation in the body; second to potassium in 
its intracellular concentration; and participates in various biological reactions (Aikawa, 
1971; Kantak, 1988). The human male, with a weight of 70 kg, contains 21-28 g of 
magnesium (Widdowson et al., 1951). Approximately one-half of the total body 
magnesium is in the bones, the remainder being almost equally distributed between 
nonmuscular soft tissues and the muscle (Flink, 1985). Normal serum magnesium values 
are 1.5-2.0 mEq/L (Rude and Singer, 1981). Walser (1967) showed that 20-30 percent of 
magnesium in blood is bound to protein; and the rest is diffusible as free ionized 
magnesium. The kidney has an important role in maintaining blood magnesium within the 
normal range by changing the tubular magnesium reabsorption through glomerular filtration 
of blood magnesium (Chesly and Tepper, 1958). Three to five percent of filtered 
magnesium is excreted in the urine, whereas the rest is reabsorbed (Dirks and Quamme, 
1978), although in the magnesium-deficient state, the renal conservation of magnesium is 
increased (Shils, 1969). 
Magnesium deficiency in man 
Magnesium deficiency is defined as a reduction in total body magnesium content 
despite the absence of clinical symptoms of magnesium deficiency. There are many criteria 
to establish the subclinical deficient state: magnesium balance, muscle analysis, 
exchangeable magnesium determined by radioisotopes, retention of magnesium after acute 
parenteral administration, serum magnesium concentration and magnesium level in 
erythrocytes (Agarwal and Agarwal, 1976). Clinical identification of magnesium 
deficiency is dependent on the recognition of hypomagnesemia (Whang, 1984). 
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Magnesium deficiency symptoms in humans include neuromuscular dysfunction, 
behavioral disturbance and cardiovascular abnormalities, particularly muscular twitching 
and tremor of varying of any or all muscles; including the tongue. Convulsions occur in 
severe depletion and are the signal of magnesium deficiency in infants and young children 
(Bronner and Coburn, 1981; Flink, 1976; Rude and Singer, 1981). 
Symptoms and biochemical features of magnesium deficiency have been studied 
experimentally by producing magnesium deficiency in humans (Shils, 1969) and in animal 
models (Buck et al., 1978). Magnesium deficiency in humans leads to neuromuscular 
hyperexcitability and disturbances (Flink, 1985). Patients may present with tetany, leading 
to generalized tonic-clonic seizures as well as focal seizures. Also, ataxia, muscular 
weakness, depression , irritability and psychotic behavior have been found. These 
symptoms are reversed by treating with magnesium (Goodman and Knobil, 1961). Tetany 
is the most distinctive symptom in hypomagnesemic patients who have normal serum 
electrolyte concentrations and normal acid-base balance (Vallee et al., 1973). 
Most patients with hypomagnesemia have serum magnesium concentrations less 
than 1 mEq/L. Biochemical changes; in addition to hypomagnesemia ; found in 
magnesium-depleted patients are hypokalemia, hypocalcemia and hyperphosphatemia due 
to either defective release of parathyroid hormone, resistance to the peripheral effects of the 
hormone or a combination of the two (Nesbakken and Reinlie, 1985; Whang, 1984; 
Whang et al., 1985). In contrast , Graber and Schulman (1986) reported that hypocalcemia 
caused by hypomagnesemia is independent of the effects of parathyroid hormone in 
patients . Clinical etiology of magnesium deficiency as reported by Flink (1985) include the 
following descriptions. Gastrointestinal disorder. Magnesium deficiency may occur 
with malabsorption syndrome (Agarwal and Agarwal, 1976; Whang, 1984), prolonged 
diarrhea, pancreatitis (Edmondson et al., 1952) and ulcerative colitis (Booth et al., 1963). 
Alcoholism. Magnesium deficiency may occur in chronic alcoholic patients . It was 
found that significant hypomagnesemia, positive magnesium balance during recovery, 
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significant decrease in muscle magnesium, depletion of total exchangeable magnesium and 
diuresis of magnesium were produced by ingestion of alcohol (Flink, 1985). Cirrhosis 
of the liver. Hypomagnesemia is found in cirrhotic patients due to malnutrition, damage 
to the liver or constant magnesium loss due to alcohol ingestion (Sullivan et al., 1969). 
Fluid loss. Magnesium deficiency developed due to prolonged and severe loss of body 
fluid during surgery with multiple drainage of patients (Barnes, 1969). Diabetes. A 
urinary magnesium excretion of more than 35 mEq/day in diabetes mellitus patient leads to 
hypomagnesemia (Martin, 1969). Bone diseases. Hypomagnesemia was seen in 
osteolytic bone diseases and also in hypoparathyroidism due to the transfer of magnesium 
into soft tissues or bone since urinary excretion did not change (Eliel et al., 1969; Ford et 
al., 1989). Kidney disfunction. Hypomagnesemia occurs in certain kidney diseases 
(Smith and Hammersten, 1958). Hanna and Manlntyre (1957) found that aldosterone 
increases urinary and fecal magnesium excretion. Drugs. Gentamycin, viomycin , 
capreomycin and sodium sulfate infusion causes hypomagnesemia (Bar et al., 1975). 
Diuretics, especially mercurial and thiazide; appear to cause both potassium and magnesium 
depletion by increasing urinary excretion (Hollifield, 1984; Lim and Jacob, 1972; Whang, 
1984). 
Magnesium deficiency in animals 
Magnesium deficiency has been observed in sheep and cattle in which the syndrome 
develops spontaneously. Two types of magnesium deficiency occur in cattle : (1) It 
develops in animals raised exclusively on whole milk (Allcroft, 1956) and (2) it develops in 
an endemic disease known as grass staggers or grass tetany (Aikawa, 1971; Sjollema , 
1932; Wacker and Parisi, 1968). Magnesium defeciency has been induced in weanling rats 
on a diet containing .09 mEq Mg++fkg; leading to hyperemia with vasodilatation and a 
subsequent heightening of nervous irritability and then to generalized and sometimes fatal 
seizures (Kruse et al., 1932). Rats fed a low diet level (1.8 ppm magnesium) develop 
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acute hyperemia of the skin, loss of hair and convulsions; fatalities may occur within 10-12 
days. The first phase of deficiency, lasting about 2 weeks, is characterized by vasodilation 
(reddening of the ears and feet), skin lesions, hyperemia and hyperexcitability. The second 
phase is marked by signs of malnutrition and renal damage (Aikawa, 1973). During the 
final stage of acute magnesium deficiency , a massive quantitative release of three 
catecholamine, epinephrine, norepinephrine, and serotonin occurs in rats which causes an 
extremely rapid onset and development of pulmonary edema and leads to the pathogenesis 
of the seizure-shock syndrome (Caddell et al., 1986; Weiner, 1985). These symptoms 
almost invariably culminate in death caused by a tonic seizure . A very similar effect was 
observed in dogs (Orent et al., 1932), and rabbits (Bradbury et al. , 1968) fed low-
magnesium diets. 
In hypomagnesemia, magnesium concentration in the cerebrospinal fluid (CSF) is 
greater than magnesium in plasma ultrafiltrate (Chutkow, 1971). Moreover, magnesium 
infused intravenously increases plasma magnesium level, but CSF magnesium tends to 
remain stable (Buck et al., 1978; Leaver et al., 1987). Oppelt et al. (1963) found that 
magnesium is transported from blood to CSF by an active transport mechanism, and the 
removal of magnesium from CSF to blood occurs by diffusion and bulk filtration. 
However, there is a direct relation between serum magnesium and CSF magnesium level 
(Oppelt et al., 1963). Magnesium deficiency affects losses of magnesium from the central 
nervous system in rats shortly after severe hypomagnesemia (Buck et al., 1976; Chutkow , 
1974) . There is a high correlation between plasma and cerebrospinal-fluid calcium and 
magnesium concentrations; indicating that convulsions occurred when cerebrospinal fluid 
magnesium and plasma calcium concentrations decreased (Leaver et al., 1987). 
Magnesium deficiency in animals restricted to a diet containing only 2 ppm of 
magnesium manifests itself with vasodilation and a subsequent heightening of nervous 
irritability; which terminates invariably in a convulsive seizure (Kruse et al., 1932; Buck et 
al., 1978). Other phenomena, including nutritive failure and chemical changes in the 
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blood, bone and mineral excretion, likewise ensue (Kruse et al., 1934; Orent et al., 1932), 
but it is the involvement of the nervous system, the so-called local effect, that gives a 
certain specifity to magnesium deficiency. Cockburn et al. (1973) reported that neonatal 
convulsions may result from a variety of causes; including primary disturbances of mineral 
metabolism. A well-established relationship exists between magnesium status and 
excitability in mammals (Allsop and Pauli 1985; Leaver et al., 1987; Wacker and Parisi, 
1968). Buck et al. (1976), working with young rats, reported that they became hyperactive 
within a few days when fed a low-magnesium diet and, shortly thereafter, became highly 
susceptible to audiogenic seizures. 
Magnesium deficiency also affects other electrolytes and metabolites. Magnesium 
depletion caused hypocalcemia by direct action on bone due to its effect on calcium 
absorption (Graber and Schulman, 1986). Dietary magnesium depletion in rats is 
accompanied by muscle potassium depletion (Whang et al., 1985). Concurrent 
hypomagnesemia among hypokalemic patients has been estimated to be between 38 percent 
and 42 percent (Boyd et al., 1983; Whang, 1984; Whang et al., 1985). A similar result 
was found between the magnesium and calcium in the extracellular and intracellular fluids. 
Wacker and Parisi (1968) also found that greater intracellular (Mg++)/(Ca++) and 
(K+)/(Na+) ratios accompany a higher metabolic activity of cells. Calcium, sodium, 
potassium and total and ultrafiltrable magnesium were decreased, while brain, muscle and 
CSF retained normal concentrations of magnesium; slight changes occurred in brain Na and 
K. Magnesium depletion in animals results in a decrease of potassium and increased 
sodium levels in muscle and heart (Whang et al., 1985). 
Magnesium homeostasis 
The homeostasis of magnesium is dependent on intake, absorption and excretion. 
Daily intakes among individuals varied greatly from 132 to 350 mg for women and from 
157 to 595 mg for men (Lakshmanan et al., 1984). Absorption of magnesium from the gut 
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and its excretion by the kidneys are the main factors determining serum magnesium levels 
(Massry and Coburn, 1973). 
Magnesium reabsorption in the nephron is affected by a number of physiologic and 
metabolic factors; as well as by drugs and disease states. Hypermagnesemia, 
hypercalciuria, hyperthyroidism, alcoholism, diuresis, nephrotoxic drugs and acidosis 
increase excretion of magnesium (Hulter and Paterson, 1984; Meyer, 1989). In contrast, 
hypomagnesernia, hypocalcernia and alkalosis decrease magnesium excretion (Ford et al., 
1989; Graber and Schulman, 1986). In addition, a number of hormones affect magnesium 
reabsorption by the kidney . Parathyroid hormone (PTH) participates in the regulation of 
magnesium homeostasis. Excesses of parathyroid hormone cause negative magnesium 
balance by increasing urinary excretion and decreasing gastrointestinal absorption. Serum 
magnesium levels decrease; but cellular magnesium concentration is unchanged due to 
ancillary protective mechanisms (Hulter and Paterson, 1984). Nonetheless, 
hypomagnesernia leads to inhibition of thyroid hormone synthesis by reducing the 
efficiency of the iodine-trapping mechanism. Hence, excess production of thyroid 
hormone is moderated, causing in turn better magnesium balance and less hypomagnesemia 
(King and Stan bury, 1970). Calcitonin can reduce magnesium excretion by increasing 
loop reabsorption (Marone and Sutton, 1983). However, the administration of calcitonin 
in humans results in increased or an unchanged urinary magnesium excretion (Cockburn et 
al., 1973). Also, thyroid hormone and aldosterone are involved in magnesium 
homeostasis; with an increase in these hormones, intestinal magnesium absorption is 
decreased and urinary magnesium excretion is increased (Wacker and Parisi, 1968; 
Wallach, 1976). Magnesium metabolism is also affected by adrenocorticoids due to their 
ability to expand fluid volume; causing hypermagnesernia. Serum magnesium decreases, 
leading to impaired adenylate cyclase activation by acetylcholine due to decreased 
adrenocortical secretion rates which in turn improves magnesium balance (Wallach, 1976). 
Growth hormone, insulin and glucagon in hypoglycemia usually cause hypomagnesernia 
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by stimulating cellular influx of magnesium. Increased cell-magnesium concentration in 
islet beta cells leads to displacement of cell calcium and a reduction of calcium secretion. 
The consequent decrease in insulin secretion leads to normal serum and cell magnesium 
concentrations (Wallach, 1976). 
Magnesium and calcium share the same transport systems in the gut and kidneys 
(Massry and Coburn, 1973) and are affected by parathyroid hormone (PTH) and vitamin 
D. Since magnesium and calcium share a common transport system in the kidney, the 
increased filtered load of calcium inhibits the tubular reabsorption of magnesium, which, in 
turn, overcomes any direct effect of parathyroid hormone on the tubular handling of 
magnesium (Wilkinson, 1976). 
The intestinal and renal conservation and excretion mechanisms in normal subjects 
permit homeostasis over a wide range of dietary magnesium intake. When magnesium 
intake is low in normal humans, magnesium output becomes very small (Shils, 1969). 
Supplementing the normal magnesium intake increases urinary excretion without changing 
normal serum levels (Heaton, 1969). 
Carbohydrate metabolism and magnesium 
Insulin plays an important role in the development of the hypertriglyceridemia 
associated with magnesium deficiency (Bennett et al., 1969). Magnesium affects insulin 
secretion by changing the sensitivity of the beta cells of the pancreatic islets to glucose 
(Curry et al., 1977). McNeill et al. (1982) confirmed these results; showing that increased 
phosphoenolpyruvate carboxykinase activity, due to magnesium deficiency, leads to 
increased hepatic glucose production so blood glucose level also increases and insulin 
levels are low. 
Legrand et al. (1987) found a complex interplay between serum magnesium and 
glucose metabolism; chronic magnesium deficiency alters several parameters of glucose 
homeostasis in the rat by exhibiting a poor insulin response to glucose . Glucose 
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metabolism may affect magnesium status of the body; diabetes mellitus is frequently 
associated with hypomagnesemia (Mather et al., 1979). Decreased serum magnesium 
concentration is inversely related to the quality of blood glucose control in indi_yiduals with 
diabetes (Mather et al., 1979; Yajnik et al., 1984). Hypomagnesemia mostly results from 
increasing excretion of magnesium in urine and a substantial depletion of body magnesium 
stores. Lostroh and Krahl (1972) found that an insulin dose causes a net increase in the 
accumulation of magnesium and potassium in the retrogressed uterus and that a functioning 
ion pump is one requisite for this action of insulin. 
On the other hand, magnesium may also influence glucose homeostasis. Moles and 
McMullen (1982) reported that hypomagnesemia could cause insulin resistance during 
treatment of diabetic ketoacidosis. In in Yi.lrQ studies, magnesium plays an important role 
in the action of insulin, and magnesium was also involved in the regulation of the beta-cell 
functions due to the inhibition of insulin release and biosynthesis (Lostroh and Krahl , 
1972). Lowering extracellular magnesium inhibits insulin secretion and stimulates insulin 
biosynthesis by isolated rat islets (Lin and Haist, 1973). Curry et al. ( 1977) reported that 
Ca++fMg++ ratio in the serum is a primary regulator of the insulin secretory process, since a 
relatively slight alteration of the physiologic ratio of Ca++/Mg++ (approximately 2.5) results 
in a marked inhibition of total insulin secretion. This dependency on magnesium may 
reflect the fact that magnesium is required for many processes, including enzyme reactions 
catalyzed by ATP (Rubin, 1975; Wacker and Parisi, 1968). Magnesium dependency may 
also be related to the importance of magnesium for increasing hormone-receptor affinity, as 
in posterior pituitary hormones and vascular smooth muscle (Somlyo et al., 1966). 
Cerebrospinal fluid-magnesium 
Rat brain mitochondria phosphotransferases, such as creatine kinase and adenylate 
kinase, are activated by magnesium (Sugano et al., 1972). Magnesium and potassium 
exert a direct stimulatory effect on the penetration of substrates into brain mitochondria in 
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various metabolic states (Sugano et al., 1972). Magnesium is essential for membrane 
integrity, ATPase functions and the synthesis of co-factors such as coenzyme-A (CoA) and 
thiamine pyrophosphate (Aik:awa, 1981). Magnesium also plays an important regulatory 
role in the gating of excitatory amino-acid neurotransmitter channels within the brain 
(Nowak et al., 1984 ). Excitatory amino-acid neurotransmitters; such as glutamate and 
aspartate; participate in tissue damage caused by cerebral ischemia and brain injury (Choi, 
1987; Rothman and Olney, 1986). Altura et al. (1984) reported that magnesium ion plays 
an important role in the regulation of cerebral vascular tone by inducing a rapid; 
spontaneous vascular tone in cerebral arteries and veins of different species (rats, rabbits, 
dogs, pigs and human) with the lowering magnesium content of cerebral blood v..essels. 
Magnesium concentration in cerebrospinal fluid (CSF) is higher than in serum, and 
this level remains stable in case of changing plasma concentration (Cohen, 1971). 
Magnesium moves rapidly from plasma into the ventricular fluid against an electrochemical 
gradient by active transport across the epithelial cell of the choroid plexus (Flatman, 1984; 
Oppelt et al., 1963 ). Direct influx of magnesium into a normal brain through the cerebral 
capillary endothelial blood-brain barrier is slow (Ginsburg, 1973). However, magnesium 
may be transported actively across the blood-brain barrier into the cerebral cortex to 
maintain a higher magnesium concentration in the cortical interstitial fluid than in the 
ventricular fluid (Bito, 1969). The choroid plexus is involved in maintaining the constancy 
of the cerebrospinal fluid magnesium concentration by sensing changes in the normal 
cerebrospinal fluid magnesium concentration and altering its rate of active secretion of 
magnesium (Bradbury and Sarna, 1977; Reed and Yen, 1978). Magnesium deficiency due 
to a low-magnesium diet appears first in serum, followed-by a decrease in CSF 
concentration (Allsop and Pauli, 1985; Buck et al., 1976; Chutkow, 1974; Fisher et al., 
1985). Tufts and Greenberg (1938) found a reduction of about two-thirds in whole-body 
magnesium in weanling rats, whereas only 18 percent reduction in CSF magnesium 
occurred due to a magnesium-deficient diet. Other investigators showed a sharp decrease 
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in serum magnesium, while little change occurred in the CSF or whole brain due to a low-
magnesium diet (Bradbury et al., 1968). Chutkow (1974) observed that the maximal 
degree of magnesium loss is 10 percent smaller in whole-brain than in muscle, plasma or 
serum due to a magnesium-deficient diet. This loss was accompanied by an increase in 
nervous system hyperexcitability and seizures in rats. Buck, et al. (1976 and 1979) 
confirmed these observations. 
Nerve impulse conduction 
In nerve conduction, magnesium and calcium stabilize the transmission of axonal 
impulses. Calcium and magnesium function in a parallel manner in this process of synaptic 
transmission. Calcium is required for synaptic transmission because it plays a permissive 
role in acetylcholine secretion at the neuromuscular junction. Magnesium antagonizes the 
Ca++- dependent release of acetylcholine at the motor endplate. There is a competition 
between calcium stimulation and magnesium inhibition of acetylcholine release. A similar 
antagonism exists between calcium and magnesium in the mammalian brain. In the brain, a 
high magnesium concentration appears to promote acetylcholine synthesis and inhibit its 
release (Wacker, 1980). In contrast to the antagonistic roles in the conduction of nerve 
impulses and normal muscle contraction, the effect of decreases in magnesium and calcium 
concentrations leads to enhanced neural excitability by decreasing membrane surface charge 
screening and thereby to enhanced activation of inward currents (Mayer et al., 1984; Mody 
et al., 1987). Changes in the concentration of Ca/Mg influence release of certain 
neurotransmitters. Gama-amino-butyric acid (GABA) and acetylcholine (Ach) are released 
in the superfusate of retinas during spreading-depression (SD). Decreasing calcium 
concentration from 1 to 0.5 mM and simultaneously increasing magnesium concentration 
from 1 to 2 or 4 mM led to decreased GABA and Ach release during SD (Rodrigues et al., 
1988). 
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Extracellular calcium decreases during epileptic activity in vivo caused by electrical 
convulsive shock. In neurones, a massive influx of calcium through either voltage-
dependent L-channels or receptor-operated channels (NMDA channel) is associated with 
the paroxysmal depolarization. A large increase in soma calcium concentrations could have 
a spillover effect with increases in presynaptic calcium. Calcium influx would then bind 
with calmodulin; leading to exocytosis and recruitment of additional neurones . Excitatory 
neurotransmitters would facilitate calcium entry through receptor-operated channels and 
potentially propagate seizure discharge (Meyer, 1989). Therefore, a massive entry of 
calcium into neurons occurs during seizure activity is thought to have several deleterious 
concequences including: (1) Enhanced activation of phospholipase A2 attacking cellular 
membranes and neurofilaments liberating free fatty acids and altering permeability and cell 
function , the free fatty acids can be the source of free radicals; (2) risied intracellular 
ca lcium , mitochondria will accumulate calcium which will uncouple oxid ative 
phosphorylation at a time when ATP production is reduced due to anaerobic metabolism; 
(3) altered receptor function , binding to the receptor would directly gate an inward calcium 
current leading to either initiation and/or propagation of an epileptic discharge ; (4) facilitate 
exocytosis of punitive neurotransmitters, glutamate and aspartate led to neuronal 
destruction through the influx of calcium. 
Magnesium concentrations have often appeared to influence the transmission of 
impulses across nerve membranes , and magnesium has been implicated in the (Na+,K+)-
A TP-ase enzyme system that contributes to changes in cation potential that occur in nerve 
membranes during depolarization (Abood, 1966). The (Na+,K+)-A TPase (Na+,K+ pump) ; 
an enzyme located in the plasma membrane of eukaryotic cells; actively transports Na+ and 
K+ across the membrane (Askari, 1982; Skou, 1965). Sodium and potassium are actively 
transported in a large number of cell types, including those of the nervous system (Albers, 
1967). Sodium is transported from the cytoplasm to the interstitial fluid against an 
electrochemical gradient by active transport (Ussing, 1960). This active transport requires 
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energy; which comes from ATP (Hoffman, 1960). As the concentrations of either Na+ or 
K+ are increased (the other being held constant); ATPase activity increases (Buck et al., 
1979; Pedemonte and Beauge, 1986). (Na+, K+)-A TPase has been characterized in rat 
brain microsomal fractions; and its activity is stimulated when sodium, potassium and 
magnesium ions are present but is inhibited by the presence of calcium ion (Kauppinen et 
al., 1986; Rohani et al., 1982). (Na+,K+)-ATPase is also localized in the somatosensory 
cortex; especially fibers (axons and dendrites) of the rat brain (Stahl and Broderson, 1976). 
There is a high association between magnesium-deficiency and (Na+,K+)-ATPase 
activity. That (Na+,K+)-ATPase activity is decreased in magnesium-deficient rats may 
reflect a cellular action to counter the increased excitability due to the magnesium deficiency 
by increased (Na+,K+)-A TPase activity (Buck et al., 1976; Chutkow, 1974). 
The (Na+,K+)-ATPase has been widely implicated as the enzyme involved in the 
active transport of cations across cell membranes that maintain resting potentials in nervous 
tissue (Skou , 1965) due to the conversion of chemical energy into electrical potential by 
ionic movement. A direct correlation has been reported between excitability and 
intracellular sodium; epileptic seizures result when intracellular sodium levels increase and 
when potassium levels in the cerebrospinal-fluid decease (Viukari, 1979). The activity of 
(Na+,K+)-ATPase, which maintains intracellular Na+ at a low level, intracellular K+ at high 
levels and resting membrane potentials in nervous tissue, depends on many factors; such as 
concentrations of ATP, magnesium, sodium, potassium, calcium and inorganic phosphate 
concentrations (Reuss et al., 1984; Whang, 1984). Wacker and Parisi (1968) found that 
magnesium depletion causes a slowing of the pumping mechanism that maintains normal 
intracellular sodium and potassium gradients. Therefore, an abnormal flux of monovalent 
cations may be related to the epileptogenic process in humans. Such an abnormality may 
be linked to an alteration in the activity of (Na+,K+)-ATPase (Rapport et al., 1975). A 
reduced (Na+,K+)-ATPase activity in human epilepsy has been reported (Rapport et al., 
1975). Also, it was found that (Na+,K+)-ATPase activity decreased in experimental brain 
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injury (Lim and Jacob, 1972), from hypoxia (Stastny et al., 1971) and from injection with 
pentylenetetrazol (Bignami et al., 1966). Enzyme activity was completely inhibited by 
ouabain , which also blocks active sodium and potassium transport (Donaldson et al., 1971; 
Swanson and Stahl, 1972). It was found that zn+2 and cu+2 inhibit (Na+,K+)-ATPase 
activity and causes seizures in rats (Donaldson, et al., 1972). All of these conditions lead 
to increased seizure susceptibility. 
N-methyl-D-aspartate (NMDA) is a synthetic analogue of aspartic acid that 
selectively activates a unique receptor on vertebrate neurones. The NMDA response is 
greatly potentiated by reducing the extracellular magnesium ion concentration below the 
physiological level (-1 mM) (Ault et al., 1980; Coan and Collingridge, 1985). In 
magnesium-free solutions, NMDA opens cation channels, especially those for Na+ and 
K +. Furthermore, the voltage dependence of the conductance does not result from a direct 
effect of the membrane potential on the receptor-channel complex but rather is the 
consequence of a voltage-dependent Mg++ blockade (Ascher and Nowak, 1988; Hegstad 
et al., 1989; Mody et al., 1987; Nowak et al., 1984; Stanton et al., 1986). A voli et al. 
(1987) indicated that NMDA conductances are important for the genesis of seizure-like 
discharges in human epileptogenic neocortical slices. Lowering extracellular magnesium 
concentration to zero induced spontaneous epileptiform activity in the mature nervous 
system that consisted of bursts of low-amplitude isolated discharges lasting 50-90 sec, 
recurring every 90-300 sec. Application of the NMDA receptor antagonist DL-2-amino-7 
phosphonoheptanoic acid caused a rapid, reversible suppression of epileptiform activity 
(Hegstad et al., 1989; Jones and Heinemann, 1988). 
A well-established relationship exists between neurotransmitter abnormalities and 
seizure susceptibility (McNamara, 1984; Poenara et al., 1984). Several neurotransmitters 
contribute to this. One group of those neurotransmitters; secreted and stored in the adrenal 
medulla; is the catecholamines, which play an important role in increasing and decreasing 
blood pressure, exciting the nervous system and increasing cardiac output (Classen, 1981; 
Gorbman et al., 1983; Kutsky, 1981). 
Catecholamines, norepinephrine, epinephrine and dopamine, increase serum 
magnesium concentration in rats (Bronner and Coburn, 1981). Norepinephrine has been 
found to enhance brain (Na+,K+)-ATPase activity (Yoshimura, 1973) or have no effect on 
the activity of the enzyme (Logan and O'Donovan, 1976). Gorbman et al. (1983) reported 
that catecholamine retention in adrenal medulla requires ATP, magnesium and A TPase. 
Magnesium ion inhibits release of the catecholamines; which calcium ion enhances their 
release (Gorbman et al., 1983). Catecholamine depletion, especially norepinephrine; 
induces seizure susceptibility in rats (Burley and Ferrendelli, 1984; Woodbury, 1984). 
Dopamine increases hyperexcitability in animals, perhaps by increasing (Na+,K+)-
A TPase activity (Yoshimura, 1973). Dopamine concentration has been reported to increase 
in a magnesium-deficient rat brain (Poenaru et al., 1984 ). Gunther and Ising (1979) found 
that urinary excretion of catecholamine was increased when rats were exposed to a 
combination of magnesium-deficient diet and noise. 
Serotonin (5-hydroxytryptamine) is a monoamine of the brain associated with 
convulsions and hyperexcitability when depleted (Pycock et al., 1978). Serotonin 
contributes to ATPase activation in the cerebral cortex by increasing (Na+,K+)-ATPase 
activity (Yoshimura, 1973). Decreasing serotonin synthesis increases seizure susceptibility 
(Browning, 1985; Laird et al., 1984). Serotonin concentration is higher in the brain of 
magnesium-deficient rats that are susceptible to audiogenic seizures (Buck et al., 1979). 
Chaistitwanich et al. (1987) reported that magnesium-deficient rats show increased 
serotonin and dopamine concentrations in the cerebral cortex, cerebellum, medulla 
oblongata and pons. However, Chutkow (1980) reported no change in brain serotonin, 
but the serum serotonin concentration increases in magnesium-deficient rats. 
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Fasting 
Over 70 years ago, Benedict (1915) published data on the metabolism of fasting in 
humans in which he demonstrated that carbohydrate stores provide a small but significant 
component of the body's fuel for only the first few days. Thereafter, protein and fat are the 
sole sources of fuel, the former contributing 15 percent of the calories and the latter the 
balance. It was readily apparent that glucose has to be derived from protein to maintain 
cerebral metabolism during a prolonged fast. More recently, understanding of the fasted 
state has been further clarified by the demonstration that free fatty acids are both the major 
transport form of lipid-leaving adipose tissue (Dole, 1956) and the energy substrate that is 
readily utilized by liver, muscle and many other tissues (Gordon and Cherkes, 1956). 
Mcllwain (1959) also found tissues preferentially use carbohydrate for energy over fat and 
protein. The quantity of carbohydrate stored can supply the required energy for the body to 
function for about one-half day; thereafter, protein and fat are the primary sources of fuel. 
Fasting for five days caused a decrease in body weight, reduction in metabolic rate 
by 26 percent, quantitative reduction in energy expenditure due to energy conservation, a 
reduction in cardiac output and a decreased blood flow through the heart, portal-drained 
viscera, white adipose tissue, leg muscle, hindquarters and in the whole-body muscle (Ma 
and Foster, 1986). In response to food deprivation; protein synthesis in skeletal muscle 
decreases and the muscle protein degradation rate decreases (Li and Goldberg, 1976). 
Longer periods of fasting diminish the muscle RNA levels and inhibit protein synthesis (Li 
et al., 1979). 
Starvation is characterized by an increased availability of free fatty acids (FFA) for 
cellular oxidative metabolism and a decrease in their esterification rate. Also, starvation 
blocks both the glucose-induced stimulation and inhibition of insulin and somatostatin but 
does not affect glucagon secretion (Rodriguez et al., 1984). Mobilization of fatty acids is 
increased by the action of the pituitary gland and the adrenal cortex hormones in fasting 
animals (Cahill et al., 1966; Fain, 1962; Goodman and Knobil, 1961). 
23 
Dumbauld et al. (1983) studied carbohydrate metabolism during a 72-h fast in 11 
nondiabetic; endstage renal disease (ESRD) patients on chronic hemodialysis and six 
normal subjects. Serum potassium concentration was significantly higher in the ESRD 
patients; and two patients were removed before completion of the fast when severe 
hyperkalemia developed. Mean blood glucose, alanine, pyruvate, beta-hydroxybutyrate 
and serum insulin concentration were similar in the two groups. Mean blood acetoacetate 
and plasma free fatty acids (FF A) concentration were lower in the ESRD group. 
Rodriguez et al. (1984) found that a 48-h fast blocked the glucose-specific effect on 
islet secretion and inhibited insulin and somatostatin secretion due to the insulin secretory 
defect; as previously reported by Boden et al. (1981). Starvation increases the secretion 
rate of glucagon, epinephrine and norepinephrine; which facilitates release of glucose from 
the liver, thereby contributing to the maintenance of the blood glucose concentration above 
the lower limit of the physiological range . The sympathetic nerves stimulate release of 
epinephrine and norepinephrine by adrenal medulla, resulting in release of glucose from the 
liver (Niijima, 1986). 
Starvation for 72h affects the hormonal response of pancreatic islets in vitro by 
inhibiting insulin and somatostatin secretion without changing glucagon release (Efendic et 
al., 197 6). Starvation has no effect on the time kinetics of the insulin response (Efendic et 
al., 1976). Bouman et al. (1979) reported that fasting for 24 and 72h caused inhibition of 
glucose-induced insulin secretion; both in vivo and in YitrQ. Also, increasing duration of 
fasting more than 72h delayed and inhibited the c-AMP response to glucose. Crespin et al. 
(1973) demonstrated that the insulin secretory response to glucose is already strongly 
impaired after 24h of food deprivation. 
The pituitary, adrenal and thyroid glands, while not initiating FFA mobilization 
during fasting, nevertheless, modify the response; and optimal function of these glands is 
requisite for normal FF A mobilization due to food deprivation (Goodman and Knobil, 
1961). Tegelman et al. (1986) reported that growth hormone secretion increases during 
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fasting. Mlekusch et al. (1975) reported an increased FFA level in rats during a 12-h fast 
due to a decrease in reesterification of FFA in the fat cell caused by lack of glycerol-3-
phosphate. 
Magnesium depletion in humans has been studied in association with various 
chronic illnesses (Flink, 1976; Flink, 1985). Magnesium depletion is induced 
experimentally in healthy subjects and in animals by using a magnesium-deficient diet 
(Drenick et al., 1969; Kruse et al., 1932). Subjects that fast for a long time excrete sizable 
quantities of magnesium and other minerals (Elia et al., 1984). An 18 days fast undertaken 
by 19 obese male subjects resulted in no change in plasma magnesium concentration, while 
urinary magnesium loss and muscular magnesium continued to be depleted (Drenick, 
1964). Drenick et al. (1969) found that fasting 60d induces magnesium depletion, and the 
deficit may reach 20 percent of the total body magnesium content. Most of the magnesium 
loss occurs via the kidney; but in some subjects the intestine functions as an additional 
excretory organ for magnesium throughout fasting. 
Fasting affects mineral metabolism by increasing magnesium and potassium 
excretion (Sapir et al., 1976; Stewart and Fleming, 1973) . Elia et al. (1984) reported that 
plasma and urine calcium, magnesium, phosphate and sulphate were unchanged during 
four days of total starvation in five healthy non-obese young adults. Francesconi and 
Hubbard (1985) observed that food deprivation for 24, 48 or 72h and exercise (9.14 
m/min) in the heat (35 .5 OC) causes hypoglycemia in the rats. Those decrements in 
glucose concentrations were accompanied by decreases in circulating insulin values. Also, 
prolonged fasting, for 48 and 72h, caused significant hypertriglyceridaemia and hyperlactic 
acidemia. Sodium and potassium levels were unchanged. 
Rapport et al. (1965) reported that plasma potassium concentration decreased 
during fasting. Also, Stewart and Fleming (1973) observed decreased erythrocyte 
potassium concentrations during 18 days of fasting in male patients who had a decreased 
plasma magnesium, but potassium did not change in patients given-magnesium 
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supplements . Serum potassium concentration was higher in endstage renal disease patients 
on chronic hemodialysis during a 72-h fast (Dumbauld et al., 1983). 
A strong relationship (r= 0.69, p<0.001) was found between degree of insulin 
resistance and fasting insulin levels in normal and diabetic subjects (Olefsky et al., 1973). 
When a known cause of insulin resistance is present, such as acromegaly, uremia, corticoid 
treatment, estrogen injection or lipodystrophy, it possibly will account for the correlation. 
Newman and Brodows (1983) showed that fasting markedly reduced glucose utilization at 
all insulin infusion rates, due to the affect of starvation which may alter the onset of insulin 
action or delys insulin delivery to its site of action. 
A complex relationship exists between magnesium and glucose metabolism. 
Hypomagnesemia has been found in both insulin-dependent and noninsulin-dependent 
diabetic patients (Mather et al., 1979; Yajnik et al., 1984). Yajnik et al. (1984) found that 
fasting plasma magnesium was lowest in the insulin-treated diabetic group (mean, 2.0 
mg/lOOml), intermediate in the nondiabetic (2.2 mg/lOOml) and highest in the noninsulin-
treated diabetics (2.3 mg/100 ml). In all diabetic subjects, plasma magnesium 
concentrations were inversely related to plasma glucose values and in noninsulin-treated 
patients to plasma insulin concentration . Hypomagnesemia could cause the insulin 
resistance of diabetic ketoacidosis (Moles and McMullen, 1982). As mentioned earlier, 
magnesium has an important role in the action of insulin (Lostroh and Krahl, 1972). 
Magnesium is also involved in insulin secretion via regulation of the beta-cell function 
(Curry et al., 1977). Legrand et al. (1987) concluded that, in magnesium-deficient rats, 
magnesium exerts complex effects on glucose homeostasis, with magnesium deficiency 
decreasing pancreatic insulin store and secretion of insulin. 
Starvation and diabetes lead to a catabolic state. Free fatty acids (FF A), acetoacetate 
and B-hydroxybutyrate, compete as fuels for muscle metabolism. During prolonged 
starvation in man, free fatty acids displaced ketone bodies as the preferred fuels for 
oxidation in striated muscle (Owen and Reichard, 1971). Owen et al. (1973) concluded 
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that; during starvation or diabetic ketoacidosis; the ketone bodies concentration in blocxl 
exceeds those of FF A. Cahill et al. ( 1966) demonstrated the predominance of lipid as fuel 
during fasting and emphasized the lowering of glucose metabolism particularly by the brain 
in humans who survive prolonged starvation and spare protein as gluconeogenesis 
decreases. In addition, blood-brain concentration differentials for ketone bodies exceed 
those for free fatty acids; Hawkins et al. (1971) suggested that relative impermeability for 
these substrates into other tissues may be a factor limiting rate of their metabolism. Plasma 
ketone bodies, 8-Hydroxybutyrate and acetoacetate, were highest, and plasma glucose 
concentration was lowest after 48h of starvation (Owen et al., 1973). Fasting experiments 
have demonstrated the tendency to develop hypomagnesemia and the rapid production and 
utilization of ketones to spare glucose in young children (Lacers et al., 1985; Lacers et al., 
1987; Nosadini et al., 1980; Saudubray et al., 1981). 
A theory has evolved that during starvation, the production of ketone leads to 
stimulation of the secretion of insulin; which in tum acts to modulate the release of free 
fatty acids from adipose tissue (Madison et al., 1964). Jenkins (1967) discussed this 
theory and found that in rats, the ketone bodies stimulate insulin secretion and, after a 
period of time, cause diabetes on daily administration of sodium acetoacetate. Injestion of 
sodium acetoacetate lowered the fasting plasma free fatty acids and blocxl glucose in healthy 
humans. 
Milk fat provides two metabolites, acetoacetate and 8-hydroxybutyrate. Edmond et 
al. (1985) support the concept t_hat the developing brain prefers ketone bodies as a substrate 
for the supply of carbon for respiration and lipogenesis. The developing brain enhances 
enzymatic potential to use ketone bodies in the mitochondrial compartment to support 
respiration and in the cytosolic compartment to support lipogenesis. Aging is associated 
with increased susceptibility to fasting-induced hyperketonemia after 18h of fasting in 
humans (London et al., 1986). Intravenous infusion of sodium acetoacetate or by a 48-h 
fast shown that ketone bodies are major metabolic fuels for the brain of the suckling rat 
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under normal conditions (Hawkin et al., 1971). Thus, in the brain of suckling rats ketone 
bodies appeare to be as important as glucose as a source of metabolic fuel. 
Ketogenic diet 
Many earlier investigations showed which starvation and metabolic acidosis 
reduced convulsions in epileptic children. A ketogenic diet which produces metabolic 
acidosis reduces the incidence of seizures in epileptic children (Geyelin, 1971; Peterman, 
1946; Wilder, 1921). 
A ketogenic diet was introduced as a form of antileptic treatment by Wilder (1921). 
Ketogenic diets have been effective in the treatment of akinetic or myoclonic seizures and 
petit mal epilepsy (Dodson et al., 1976; Huttenlocher et al., 1971). This diet is most 
effective in 2-5 year-old children (Menkes, 1976). Ketogenic diets have anticonvulsant 
value, and in addition, mental function is not dulled as with the use of drugs (Talbot et al., 
1926). McQuarrie and Keith ( 1957) reported that ketogenic diets forestalled mental 
deterioration and structural damage to brain by preventing seizures during the growth 
period . Berman (1975) confirmed this, and in addition, found that children became more 
alert, steady and sociable when their seizures were controlled by the diet. This was also 
one of Livingston's (1975) findings. 
Ketogenic diets prevent electroshock seizures in animals (Appleton and De Vivo, 
197 4; Uhlemann and Neims, 1972). In children, the anticonvulsant effects of a ketogenic 
diet do not appear for a few days; even though blood ketone concentrations increase 
rapidly. Withrow (1980) concluded that the anticonvulsant effect of a ketogenic diet is 
associated with how blood ketone bodies are involved in brain energy metabolism and is 
not the result of water, electrolyte, acid-base or lipid fluctuations in the brain. Ingestion of 
excess glucose, which blocks ketone production; can rapidly negate the anticonvulsant 
effect of the diet (McQuarrie and Keith, 1957). Also, Talbot et al. (1926) and Hughes and 
Jabbour (1958) found that if an excess of any kind of carbohydrate is taken by the epileptic 
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patient, the ketosis disappears and seizure attacks recur. Edmond et al. (1985) 
demonstrated that ketone bodies, acetoacetate and B-hydroxybutyrate are preferred 
substrates for the supply of carbon to respiration and lipogenesis in the developing brain of 
rats. Astrocytes oligodendrocytes and neurons from developing brain of rats have an 
excellent ability to use ketone bodies for respiration. 
Convulsive attacks stop in children (ages 2-12 years) after a 24-h fast (Menkes, 
197 6; Mike, 1965). In epileptic children treated by fasting and ketogenic diet, there is an 
increase in the production of ketone bodies concentration and a decrease in the blood sugar 
concentration (Talbot et al., 1926), which are associated with a diminution or cessation of 
convulsion. 
The use of medium-chain triglycerides (MCT) as an alternate fat for a ketogenic diet 
has been advocated by Huttenlocher et al. (1971). These triglycerides have primarily eight 
and ten carbon-atom fatty acids (three-fourth octanoic and one-fourth decanoic with trace 
amounts of caproic and lauric acid) (Senior, 1968) and are highly ketogenic (Bach et al., 
1972). The fats have a low melting point, a small molecular size and a high solubility in 
water. Therefore, these fats are readily absorbed and hydrolyzed by intestinal mucosa 
(Greenberger and Skillman, 1969; Hashim et al., 1965). After MCT hydrolysis, almost 90 
percent of free fatty acids are transferred directly to the liver through the portaf vein (Bloom 
et al., 1951). 
The commercial source of medium chain triglycerides is an oil consisting of mixed 
triglyceride of fatty acids with a chain length of six to ten carbons, approximately 71 
percent octanoic acid, 23 percent decanoic acids with a minor amount of longer and shorter 
chain fatty acids. The greater ketogenic effect of MCT compared to other types of fat is 
attributed to their rapid absorption and metabolism (Greenberger and Skillman, 1969). 
MCT is absorbed and metabolized more quickly than other fats for several reasons. (1) 
There is some evidence that in humans, there exists a gastric lipase that hydrolyzes MCT 
more rapidly than other forms of fat (Cohen, 1971). (2) MCT does not require the action 
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of bile salts to be hydrolyzed to the free fatty acid form; interfacial tension between water 
and MCT is low, and MCT is thus more soluble and more easily dispersed in solution than 
other forms of fat (Senior, 1968). (3) Once hydrolyzed into the free fatty acid form, 
reesterification into the triglyceride form is not necessary for MCT to pass in and out of the 
epithelial cell as with other fats, and the medium-chain fatty acids can move about freely in 
the free fatty acid state in portal venous blood (Hashim et al., 1965). (4) Unlike other fats, 
MCT is transported directly into the liver via the portal vein, bypassing the normal route of 
delivery via the lymph system (Senior, 1968). (5) Once in the liver, MCT fatty acids are 
rapidly metabolized and degraded into two-carbon fragments. The perfusion of the liver 
with these two-carbon fragments may occur more rapidly than the tricarboxylic acid cycle 
can accommodate them (Senior, 1968) and ketosis occurs. Signore (1973) believed that 
the magnitude of ketosis in humans was the result of carbohydrate deficiency relative to the 
amount of fat entering the liver. 
High-fat diets depress conversion of excess carbohydrate to fat in rat adipose tissue 
(Leveille, 1967). However, Theuer (1971) showed that rats fed a high MCT diet had 
enhanced lipogenesis. Infusion of MCT, octanoic (Cg), trinonanoic (C9) and decanoic 
acid (C1 Q) into the blood of dogs increased serum B-hydroxybutyrate significantly 
(p<.002), and induced significant hypomagnesemia (Guisard et al., 1973). 
Bahnsen et al. (1984) reported that ketone bodies form an important fuel source in 
fasted humans. Skeletal and cardiac muscle show high utilization rates, and even nervous 
tissue, which normally uses glucose alone, will use ketone bodies in periods of chronic 
starvation. Ketone bodies have an added importance in that high circulating levels inhibit 
protein degradation and prevent unnecessary degradation of amino acids for conversion 
into glucose for direct oxidation. 
Medium-chain triglycerides also enhanced calcium absorption in rats with bile duct 
ligation due to the "intraluminal solubilization of calcium by medium-chain length fatty 
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acid" (Kehayoglou et al., 1968). In contrast, Harrison et al. (1973) found no effect of 
MCT on the absorption of the calcium. 
Medium-chain triglyceride also enhanced magnesium absorption in rats (Tadayyon 
and Lutwak , 1969). A positive correlation between fat absorption and calcium (r= 0.84, 
p<0.001) and magnesium absorption (r= 0.54 p<0.005); respectively; has been found in 
human infants (Tantibhedhyangkul and Hashim, 1978). 
Animal care 
CHAPTER III 
MATERIALS AND METHODS 
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Male weanling Sprague-Dawley rats; 395 in number, (Simonsen Laboratories, 
Inc., Gilroy, California) were fed a control diet for at least a day and allowed to become 
acclimated before starting the experiments. They were housed individually in stainless-
steel cages with wire fronts and bottoms, and deionized water was provided ad libitum in 
polyethylene bottles having rubber stoppers and stainless-steel lick spouts. Animal-room 
temperature was maintained between 20 and 23oc. Lights were on automatically from 
0800 to 1900h daily. With and without diets consisted of 20 percent casein, 58-63 percent 
dextrose, 5 percent fat (as corn oil) , 2 percent vitamin mixture (Table 1), 5-10 percent 
mineral mixture (Table 2) and 5 percent wood fiber (alpha-cellulose). The magnesium-
deficient diet contained, by analysis, 44 mg of magnesium per kg diet. The control diet 
was prepared by adding 400 mg magnesium per kg as MgC0 3 to the deficient diet. 
Animals were weighed before initiating feeding of the control and experimental 
diets and before testing for seizures. On day 17, audiogenic seizures were induced in 
susceptible animals by the method of Patton (1941) as modified by Buck et al. (1978), 
except in experiment 1, part 1, on days 12, 14, 16 and 17 on which audiogenic seizures 
were induced in susceptible animals. Audiogenic seizure testing was performed by placing 
the rats in a metal chamber that contained two school emergency buzzers producing 115 db 
for 90 seconds. Seizure scores were rated on a scale of O to 5. Zero means no seizure; 1 
means rapid running; 2 means clonic seizures, characterized by full-body convulsion; 3 
means tonic flexion, characterized by the animal on its side, rigid and kicking; 4 means 
tonic extension , which is characterized by rigidity and extended legs; and 5 means lethal 
seizure . Because of the loud noise, testing had to be done in another room across the 
hallway with all doors closed. Animals were placed in the testing chamber cage for a few 
Table 1-- Vitamin mixture composition. 
Vitamin g/kg mixture mg/kg diet 
Vitamin A Acetate, 500,000 I.U./g 1.8 104,651 LU/kg 
Vitamin D, 850,000 I.U. Cholecalciferol/g 0.125 1,000,000 I.U/kg 
DL-alpha-Tocopherol Acetate 22.0 440 
Ascorbic Acid 45.0 900 
Inositol 5.0 100 
Choline Chloride 75.0 1,500 
Menadione 2.25 45 
P-Aminobenzoic Acid 5.0 100 
Niacin 4.25 85 
Riboflavin 1.0 20 
Pyridoxine Hydrochloride 1.0 20 
Thiamin Hydrochloride 1.0 20 
Calcium Pantothenate 3.0 60 
Biotin 0.020 0.4 
Folic Acid 0.090 1.8 
Vitamin. B-12 0.00135 0.027 
I. U. = International units 
ICN Biochemical Division of ICN Biomedicals, Inc. Cleveland, 
OH 44128 Catalog No. 904654 Lot No. 9261. 
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Table 2--Mineral mixture. * 
Salt Amount of salt, mg Mineral Mineral mg/kg diet 
MnS04 137.0 Mn 49.90 
KI 2.0 I 0.50 
FeS04.7H20 174.0 Fe 35.10 
ZnS04.7H20 53.0 Zn 12.00 
CuS04.5HzO 19.0 Cu 5.00 
Na2Mo04.2H20 12.0 Mo04 4.76 
CoCL3.6H20 4.0 Co 0.99 
Na2Se04 0.2 Se 0.09 
CrCL3.6H20 0.7 Cr 0.30 
Na2C03 1200.0 Na 510.0 
Total 1601.9 mg 
Dextrose to make 100 g 
CaC03# 12.5 g Ca 5.0 g 
NaH2P04# 15.5 g p 4.0 g 
KCL# 6.2 g K 3.6 g 
* For control diet, Mg was supplied by adding 4.0 g MgCOyk:g diet. 
# Added direct! y to the diet. 
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seconds before starting the buzzers. Death from seizures was usually prevented by chest 
massage until normal respiration had returned. On day 17, the animals were weighed, 
tested for seizures and blood samples collected by inserting capillary tubes via the retro-
ocular capillary bed. The rats were killed by decapitation immediately after blood 
collection. 
Chemical analysis 
Calcium and magnesium were analyzed in all blood samples using an 
Instrumentation Laboratories Model 457 Atomic Absorption Spectrophotometer at 422.7 
and 285 .2 nm for calcium and magnesium, respectively . One percent of 100,000 ppm 
lanthanum solution was added to minimize phosphate interferences. The solution was 
made by dissolving 234.4 gm La20 3 in 440 ml HCL; then diluting to 2L with deionized 
water. 
Phosphorus analyses were performed in all samples by method 22.042 of the 
A.O .A.C (1980) using molybdovanadate reagent; absorbance was measured at 400 nm 
with a Beckman DB-GT grating spectrophotometer. 
Potassium and sodium were measured by emission spectroscopy using the 
Instrumentation Laboratories Model 457 Atomic Absorption Spectrophotometer at 766 .5 
and 589.0 for potassium and sodium, respectively. 
Glucose was analyzed by Quantitative Calorimetric Procedure No. 635 (Sigma 
Chemical Company) in serum on the basis that, in the presence of heat and acid, 0-
toluidine reacts readily with glucose to form a colored complex. The intensity of the color 
formed was measured with a spectrophotometer at 635 nm and was proportional to the 
glucose concentration . 
Beta-hydroxybutyric acid (BHB) was measured by Quantitative Enzymatic 
Procedure No. 310-UV (Sigma Chemical Company), based on the oxidation of BHB to 
acetoacetate with the assistance of B-hydroxybutyrate dehydrogenase (BHBD) . During this 
35 
oxidation, an equimolar amount of nicotinamide adenine dinucleotide (NAO) was reduced 
to NADH + H. The consequent increase in absorbance at 340 nm due to NADH was 
proportional to the BHB concentration. 
Dietary and serum mineral analysis 
Determination of minerals in the diet in the serum were made by ashing 1-2 g of diet 
in a porcelain crucible for 48h at 55QOC. After cooling, 5-ml of 6N HCL was added, and 
the samples were slowly heated for 10-20 min to completely solubilize the ash. Then 
samples were diluted to 100-ml with demineralized water and analyzed for magnesium, 
calcium, phosphorus, potassium and scxlium (Table 3). 
Blood samples were allowed to clot in a refrigerator for approximately 2h to prevent 
glycolysis of glucose at room temperature. Then samples were centrifuged at 2000 rpm for 
30 min (relative centrifugal force, gravities= 715). Serum was transferred to a new test 
tube using Pasteur pipettes and kept refrigerated for approximately 20h before dilution for 
mineral analyses. Glucose and BHB were analyzed directly after the serum was collected. 
The serum was diluted 1: 100 by placing 0.1-ml serum into a 10-ml volumetric flask and 
diluting to volume with demineralized water. For magnesium analysis, 1-ml diluted serum 
was added to 0.1-ml of 100,000 ppm lanthanum solution in a 10-ml volumetric flask and 
brought to volume with demineralized water. This gave a final dilution of 1:1000. The 
same procedure was used for calcium. 
Phosphorus analysis was conducted by adding 1 ml of 30 percent trichloroacetic 
acid in 5-ml of the diluted serum (1:1000), stirring with a Vortex mixer, and allowing to 
stand at room temperature for 20 min (A.O.A.C, 1980; method 20.138e). The samples 
were then centrifuged at 2000 rpm for 10 min (relative centrifugal force, gravities= 715). 
One ml of molybdovanadate reagent was added to 4-ml of the supernatant, and the color 
was allowed to develop for 15 min. Optical densities of the samples were determined at 
400 nm. 
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Table 3--Concentration of minerals in diet of experiment 1 (mg/1 OOg). 
Diet Mg* ca* p* K* Na* 
Mg-supplement (control) diet 0.35 5.52 6.21 3.64 3.09 
Mg-deficient diet 0.01 5.43 5.93 3.72 3.06 
Requirement for normal growth 0.04 5.60 4.40 2.00 6.00 
* Analyzed values (mean of 3 samples). 
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Sodium and potassium were determined by diluting the serum samples 1: 100 with 
demineralized water and were measured by emission spectroscopy using the 
Instrumentation Laboratories Model 457 Atomic Absorption Spectrophotometer. 
Statistical analysis 
Experimental data were analyzed statistically using a completely randomized design 
(ANOVA) (Dowdy and Wearden, 1983). A Chi-square test was used to analyze 
differences in seizure incidence among treatments; the 5 percent alpha level was used as the 
criterion for statistical significance. Analysis of variance (ANOV A) was performed to 
determine the differences in seizure score and serum metabolite and mineral concentrations 
within and among treatments. A factorial arrangement ANOVA of treatment (3x3) was 
used in experiments 2, 3 and 4 to determine the effects of various levels of dietary MCT 
and fasting times, and the effects of gavaging various levels of BHB and glucose were 
tested at different times after dosing on serum metabolites (BHB and glucose) and mineral 
concentrations (magnesium, calcium, phosphorus, potassium, and sodium) of magnesium-
deficient rats. When "F" was significant (p<0.05), means were compared by least 
significant difference values (LSD). 
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Experimental Design 
Experiment one. The objective of the first part of this experiment was to 
determine when magnesium-deficient rats become susceptible to audiogenic-induced 
seizuring. Thirty rats were assigned to four groups as follows: (1) Six rats were tested for 
seizure susceptibility on days 2, 4 and 6 of a magnesium-deficient diet; (2) Seven rats were 
tested on days 10 and 16; (3) Seven rats were tested on day 12; and (4) Seven rats were 
tested on day 14. All rats that had not convulsed on the assigned day were retested on day 
17. Blood samples were collected for chemical analysis just after testing for seizures and 
just before killing the rats. 
The objective of the second part of this experiment was to study the effect of a 
magnesium-deficient diet and fasting on seizure susceptibility. Fasting rats were assigned 
to groups of 10 and 30 rats. The 10 rats in group one were fed the magnesium-
supplemented (control) diet, then divided into two subgroups of 5 rats each; one subgroup 
was fasted for 24h then tested for seizures; and the other subgroup was tested without 
fasting. The 30 rats in group two were divided into four groups and given the magnesium-
deficient diet and fasted for 0, 6, 12 and 24-h, respectively, before seizure testing. Blood 
samples were collected just after testing for seizures and just before killing the rats. 
Experiment two. It was found in the first experiment found that rats with high 
levels of BHB had low seizure incidence. Therefore, this experiment was designed to 
study the effects of different dietary concentrations of medium-chain triglyceride (MCT, 
ketogenic diet) on audiogenic-seizure susceptibility. MCT oil is the primary triglyceride 
fraction of coconut oil, consisting mostly of Cg and C10 saturated fatty acids, 
approximately 68 percent octanoic acid, 24 percent decanoic acid, 5 percent longer than 
C10 and 3 percent shorter than Cg fatty acids (Mead Johnson, Nutritional Division, Mead 
Johnson and company, Evansville, Indiana 47721 U.S.A.). Three diets were designed to 
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control for caloric density and percentage of energy as fat (Table 4). The first diet, 5 
percent fat, was made up of 3 percent MCT oil and 2 percent corn oil (11.8 percent of the 
kcal from fat and 3.63 kcal/g caloric density). The second diet consisted of 28 percent 
MCT and 2 percent corn oil, resulting in 54.5 percent energy from fat and 3.56 kcal/g 
caloric density. The third diet consisted of 2 percent corn oil and 21.1 percent MCT with 
53.2 percent of the energy from fat and 4.73 kcal/g caloric density. Ninety rats were 
randomly divided into 3 groups of 30 animals each. Then these 3 groups were fed a 
magnesium-deficient diet (- lOg/day) with different dietary concentrations of medium-chain 
triglyceride. After receiving the respective diets for 17 days, each group was divided into 3 
levels of fasting, 0, 12 and 24h, after which they were tested for seizure susceptibility. 
Experiment three. Because the first two experiments and earlier investigations 
on human and animal studies indicated that increased serum levels of BHB, caused by 
ketogenic diet or fasting, were associated with decreased seizure incidence, this experiment 
was designed to study the effects of acute alteration of serum BHB. The effect of gavaging 
BHB on seizure susceptibility and serum metabolites (BHB and glucose) and minerals was 
determined. Fifty-two rats were fed a magnesium -deficient diet for 17 days and were 
randomly assigned to 3 groups of 17 rats each at the start of the experiment. These groups 
were assigned to receive 0.5, 1 or 2 millimoles of sodium-beta-hydroxybutyrate, 
respectively; by gavaging, the dose was inserted directly into the stomach using a long, 
curved, blunt, stainless-steel needle through the mouth . The rats were tested for 
audiogenic seizures after gavaging as follows: 5 rats in each group were tested after 30 
min, 6 rats after 60 min and 6 rats after 120 min. Blood samples were collected just after 
testing for seizures and just before killing the rats. 
Experiment four. All three earlier experiments indicated that rats that had high 
serum levels of glucose had high seizure incidence; therefore, this experiment was designed 
Table 4--The composition and energy contribution of the ketogenic diets (MCT). 
Diet I (3%) MCT Diet II (21 %) MCT 
Diet Percent Energy Calories Percent Energy Calories 
ingredients in diet kcal/g % in diet 
MCT 3 0.25 6.9 21.1 
co 2 0.18 4.9 2.0 
Total fat 5 0.43 11.8 23.1 
Casein 20 0.80 22.04 20.0 
Dextrose 60 2.4 66.1 20.4 
Vit. mixture 2 0.0 0.0 2.0 
Min.mixture 8 0.0 0.0 8.0 
Fiber 5 0.0 0.0 26.5 
Total 100 3.63 99.94 100 
MCT, medium chain triglyceride, gives 8.3 kcal/g. 
C 0, corn oil, gives 9 kcal/g. 











Diet III (28%) MCT 
Percent Energy Calories 
in diet kcal/g % 
28 2.32 49.4 
2 0.18 3.8 
30 2.50 53.2 
20 0.80 17.0 
35 1.4 29.8 
2 0.00 0.00 
8 0.00 0.00 
5 0.00 0.00 
100 4.73 100 
"" 0 
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to study the effects of acute alteration of serum glucose levels on seizure susceptibility of 
24-h fasted, magnesium-deficient rats. Ninety-six rats were divided into 2 groups: the first 
group; comprised of 63 rats that were randomly assigned into 3 subgroups, were gavaged 
with 1.4, 2.8 or 5.6 millimoles of a 50 percent alpha-D-glucose solution, 21 rats for each 
dose level. Then 7 rats from each dose level were tested for seizures at 30, 60 or 120 min 
after gavaging the glucose. 
The remaining 33 rats were divided into 4 groups: 1) 8 unfasted rats were sham-
gavaged with 0.9 percent saline as a positive control, 2) 8 rats were fasted for 24h and 
sham-gavaged with 0.9 percent saline as a negative control, 3) 8 unfasted rats were 
gavaged with 1.4 millimoles of glucose solution and then tested for seizures after 30 min 
and 4) 9 rats were fasted for 24h and gavaged with 2 millirnoles of BHB. The gavaged rats 
were tested for seizures 30 min after receiving their respective doses. Blood samples were 
collected for chemical analysis just after testing for seizures and just before killing the rats. 
Experiment five. The purpose of this experiment was to determine the effects of 
gavaging different doses of BHB and/or glucose on seizure susceptibility of magnesium-
deficient rats . Therefore, 82 rats were divided into 8 groups as follows: group 1 was 
untreated as a control; group 2 was sham-gavaged (saline, 0.9 percent); group 3 was 
gavaged with 2.0 mmole BHB after 24-h of fasting; group 4 was gavaged with 5.6 mmole 
glucose; group 5 was gavaged with 0.5 mmole BHB and 5.6 mmole glucose; group 6 was 
gavaged with 2.0 mmole BHB and 5.6 mmole glucose; group 7 was gavaged with 0.5 
mmole BHB and 1.4 mmole of glucose; and group 8 was gavaged with 2.0 mmole BHB 





Part 1: The purpose of this experiment was to show when seizure susceptibility 
begins in weanling rats fed a magnesium-deficient diet. By days 5 to 7, the classic 
magnesium deficiency symptoms of erythema and edema of the ears, nose and claws, and 
skin lesions appeared. Edema and redness of the ears were very severe during days 7 to 
12; then, after the 12th day, these symptoms decreased in severity. The effect of duration 
of magnesium deficiency on audiogenic seizure susceptibility is shown in Figure 1. 
Severity of seizures increased erratically over time during days 12 to 17 but was greatest on 
day 17 (Fig. 1). By day 17, 100 percent of the animals were susceptible to audiogenically-
induced seizures (Fig. 1). Control animals fed magnesium-supplemented diet did not have 
audiogenic seizures. 
Part 2: The purpose of this experiment was to study the effects of a magnesium-
deficient diet and fasting on seizure susceptibility. The effect of feeding a magnesium-
deficient diet for 17 days on seizure susceptibility of the animals fasted for 0, 6, 12, 18 or 
24 hours is shown in Table 5. Compared with the animals fed magnesium-supplemented 
diet (control), all of the unfasted (0-h) magnesium-deficient rats had seizures; and none of 
the control animals had seizures (Table 5). Although the rats fasted 12 and 18h had 
reduced incidence of seizures, these reductions were not statistically significant compared 
to rats that were not fasted or were fasted for 6h. Rats fasted for 24h had reduced (p<0.05) 
seizure incidence compared with control and 6, 12 or 18-h fasting (Table 5). However, the 
correlation between hours of fasting and percentage of seizures was high, r= -0.90 (Fig. 
2). Although the rats fasted for 24h had reduced seizure scores (p<0.05) compared with 
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Fig. 1--Seizure percentage and scores of weanling rats fed a magnesium-
deficient diet that seized when exposed to a 115 db buzzer (Experiment 
1, part 1). 
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Table 5--Audiogenic seizures and serum BHB, glucose and minerals (mg/di) of rats fed a magnesium-deficient or 
magnesium-supplemented (control) diet for 17 days (Experiment 1, part 2). 
Diet Fasting Number Seizure Seizure BHB Glucose Mg Ca p K Na 
Group h of rats %# Score* 
CONTROL 0 5 o.oa o.oa 3.30a 98a 1.72a 6.78 6.06 33.2 146 
CONTROL 24 5 o.oa o.oa 50.9b 65b 1.64b 7.06 6.48 35 .7a 157 
MG-DEF. 0 6 lOOb 3.2b 3.3Qa 91a 0.59C 6.57 5.87 27.lbc 151 
MG-DEF. 6 6 lOOb 2.8bc 9.9Qa 75ab 0.67d 6.90 6.48 25.5b 150 
MG-DEF. 12 6 83b 1.6aC 16.8ac 61b 0.57C 6.60 5.22 28.7bc 155 
MG-DEF. 18 6 83b 0.8a 35.0bc 46bc 0.57C 6.20 6.67 25.9bc 158 
MG-DEF. 24 6 5Qc 1.2ac 53.6b 35c 0.56C 6.25 6.98 26.2bc 154 
NS NS NS 
a,b,c Values having different superscripts are significantly different (p<0.05). See Appendix A, Table 32. 
NS means there were no statistically significant (p<0.05) differences among the groups. See Appendix B, Table 38. 
* The higher the score; the more severe the seizures were. 
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Fasting, h 
Fig. 2--Effect of fasting on percentage of seizures and seizure score of 
rats fed a magnesium-deficient diet for 17 days (Experiment 1, part 2). 
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as compared with the unfasted magnesium-deficient rats. However, seizure score 
decreased as duration of fasting increased, r= -0.92 (Fig. 2). 
The effect of duration of fasting on serum BHB and glucose concentrations is 
shown in Table 5, Appendix D, Table 48 and Figure 3. As hours of fasting increased, 
serum BHB increased, r= 0.97, and serum glucose decreased, r= -1.00, significantly. 
While serum glucose was 91.2 mg/dl in the unfasted magnesium-deficient rats (0-h fasting) 
and 97.8 mg/dl in the unfasted control rats, by 24h fasting it had decreased to 35 mg/dl in 
magnesium-deficient rats and to 64.6 mg/dl in the control rats. In contrast, serum BHB 
increased from 3.3 mg/dl in the 0-h fasting and control rats to 53.6 mg/dl in the 
magnesium-deficient rats and to 50.9 mg/dl in the control rats after 24-h of fasting (Table 
5). Serum magnesium concentrations were markedly decreased due to feeding magnesium-
deficient diet. There were no significant differences in Ca, P and Na concentrations due to 
magnesium deficiency, but K concentration was significantly decreased in the magnesium-
deficient rats due to magnesium deficiency. 
Experiment two 
The purpose of this experiment was to study the effects of ketogenic diet (MCT) 
and fasting on seizure susceptibility of weanling rats fed magnesium-deficient diet for 17 
days. The effects of dietary MCT level (3, 21 or 28 percent in which the percentages of 
dietary energy from fat were 11.8, 54.5 or 53.2 percent, respectively, and the caloric 
densities of the diets were 3.63, 3.56 or 4.73 kcal/g) were studied (Table 4). The effects 
of different dietary concentrations of MCT and duration of fasting on seizure susceptibility 
of magnesium-deficient rats are shown in Tables 6-15. As dietary MCT level increased; 
seizure score and seizure incidence increased significantly. This effect was consistent, 
although not statistically significant between 21 and 28 percent MCT dietary levels, 
whether the rats were fasted 0, 12 or 24h (Tables 6 and 7). All of the nonfasted rats fed a 3 
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Fig. 3--The relationship between fasting times vs. serum BHB and 
glucose levels of weanling rats fed a magnesium-deficient diet for 
17 days (Experiment 1). 
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Table 6--The effect of dietary MCT levels and duration of fasting on audiogenic seizure 
susceptibility (seizure, % ) of weanling rats fed a magnesium-deficient diet for 17 days 




























1 Values having different superscripts are significantly different (p<O.OS). See 
Appendix C, Table 44, for chi-square test. 
Table 7--The effect of dietary MCT levels and duration of fasting on seizure score of 




























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 33 and 39 for ANOV A and LSD analysis. 
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5 0 
fed the 28 percent MCT diet were seized (4.73 kcal/g caloric density). Neither caloric 
density or percentage calories from fat, per se, affected seizure susceptibility. There were 
no significant differences in percentage seizures between the fasted and nonfasted rats fed 
the 21 percent or 28 percent dietary MCT. Increased duration of fasting decreased seizure 
percentages and seizure scores regardless of dietary MCT level (Tables 6 and 7). 
Information on the effect of increasing dietary MCT and fasting on serum 
metabolites of rats fed a magnesium-deficient diet for 17 days is presented in Tables 8 and 
9. The serum BHB concentration was elevated (p<0.05), from 7.1 mg/dl in the Oh-fasted 
rats fed a 3 percent MCT diet to 38.1 mg/dl in the 24h-fasted rats fed the 28 percent MCT 
diet. BHB was significantly increased within groups due to fasting and increased (p<0.05) 
among groups due to dietary MCT (Table 8). Glucose concentration was decreased 
(p<0.05) from 113 mg/dl in the 3 percent of dietary MCT to 90 mg/dl in the 28 percent of 
dietary MCT at 0-h fasting due to increase dietary MCT. Increasing duration of fasting to 
24h decreased semm glucose (p<0.05) at all levels of dietary MCT (Table 9). 
As dietary MCT level was increased, the percentage seizures, r= -0.84, and seizure 
score, r= -0.94; decreased (Fig. 4). As duration of fasting increased, seizure incidence and 
seizure score decreased at all levels of dietary MCT (Fig. 5). Serum BHB increased with 
fasting at all levels of dietary MCT, r=0.98 for 3 percent MCT, r=0.99 for 21 percent MCT 
and r=0.98 for 28 percent MCT, while serum glucose decreased with fasting at all levels of 
dietary MCT, r= -0.97 for 3 percent MCT, r= -0.99 for 21 percent MCT and r= -0.98 for 
28 percent MCT (Fig. 6). As serum BHB increased, percentage of seizures decreased, r= -
0.88, and seizure score decreased, r= -0.93, regardless of dietary MCT level or duration of 
fasting (Fig. 7, Appendix D, Table 49). Serum glucose increased as seizure percentage 
increased, r= 0.69, and as seizure score increased, r= 0.91 (Fig. 7). 
The serum mineral concentrations of the animals were not affected (p>0.05) by 
MCT level (Tables 10-15). However, prolonged fasting decreased the serum magnesium, 
5 1 
Table 8--The effect of dietary MCT levels and duration of fasting on serum BHB (mg/dl) 




























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 33 and 39 for ANOV A and LSD analysis. 
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Table 9--The effect of dietary MCT levels and duration of fasting on serum glucose 




























1 Values having different superscripts are significantly different (p<0.05). See 
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Fig. 4--Effect of MCT levels in diet on the percentage of seizures and 
seizure score of rats that had audiogenic seizures after consuming a 
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y=105.0-2. lx, r =-0.99 1:1 3% MCT 
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Fig. 5--The effect of fasting time and dietary level of MCT on the 
percentage of seizures and seizure score of rats that consumed a 



















y=l 16.5-2.9x, r=-0.97 1:1 Gluc 3% MCT 
y=76.5-1.lx, r=-0.99 • Gluc 21 % MCT 
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Fig. 6--The effect of fasting time and dietary level of MCT on serum 
glucose and BHB of weanling rats after consuming a magnesium-
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Fig. 7--The relationships between serum BHB and glucose vs. percentage of 
seizures and seizure score of weanling rats fed a magnesium-deficient diets 
with 3, 21 or 28 percent MCT and fasted 6, 12 or 24h (Experiment 2). 
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calcium, phosphorus, potassium and sodium levels (p<0.05) in all dietary MCT groups 
(Tables 10-15). 
Experiment three 
The purpose of this experiment was to determine the effects of gavaging BHB on 
serum BHB and glucose and seizure susceptibility of magnesium-deficient rats. The 
effects of gavaging 0.5, 1.0 or 2.0 mmoles of BHB and testing for seizure at 30, 60 and 
120 minutes after dosing on seizure incidence, serum BHB, glucose and mineral levels of 
magnesium-deficient rats are presented in Tables (16-21). The 1 and 2 mmole BHB doses 
resulted in decreased seizure incidence and seizure scores (p<0.05) 30 min after gavaging; 
compared with the 0.5 mmole dose (Tables 16 and 17). Waiting 120 minutes before 
seizure testing resulted in increased seizure incidence; especially in rats gavaged with 2 
mmole BHB. There was a high association between BHB dose and the percentage of 
seizures (p<0.05) regardless of testing time (Fig. 8). However, this association was 
weakest in those groups that were tested 120 min after dosing, r= -0.64 or -0.79, 
respectively. 
Tables 18 and 19 also show the effect of different BHB doses on serum 
metabolites. Serum BHB was 3.5 mgldl in the rats gavaged with 0.5 mmole BHB and was 
43.3 mgldl in the rats gavaged with 2.0 mmole BHB; but this effect was diminished with 
increasing time of dosing (Table 18). Conversely, serum glucose concentration in the 
animals given the 0.5 mmole BHB dose, 118 mgldl, was higher (p<0.05) than in rats 
gavaged with the 2.0 mmole BHB and tested 30 min later, 80 mgldl, and this effect was 
also diminished with increasing time after dosing (Table 19). There were high positive 
correlations between serum glucose and seizure percentage, r= 0.96, and seizure score, r= 
0.88, and high negative correlations between serum BHB and seizure percentage, r= -0.88, 
and seizure score, r= -0.81, (Fig. 9, Appendix D, Table 50). There was also a high 
negative association between serum BHB and serum glucose, r= -0.93 (Fig. 10). 
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Table 10--The effect of dietary MCT levels and duration of fasting on serum magnesium 




























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 33 and 39, for ANOV A and LSD analysis. 
Table 11--The effect of dietary MCT levels and duration of fasting on serum calcium 




























1 Values having different superscripts are significantly different (p<0.05) . See 
Appendices A and B, Tables 33 and 39, for ANOV A and LSD analysis. 
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Table 12--The effect of dietary MCT levels and duration of fasting on serum phosphorus 




























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 33 and 39, for ANOV A and LSD analysis. 
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Table 13--The effect of dietary MCT levels and duration of fasting on serum potassium 




























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 33 and 39, for ANOV A and LSD analysis. 
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Table 14--The effect of dietary MCT levels and duration of fasting on serum sodium 




























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 33 and 39, for ANOVA and LSD analysis. 
Table 15--Summary of the effect of dietary MCT level and duration of fasting on audiogenic seizure susceptibility and serum 
BHB, glucose and minerals of weanling rats fed a magnesium -deficient diet for 17 days (Experiment 2). 
MCT,% 3 21 28 
Fasting , h 0 12 24 0 12 24 0 12 24 
Number of rats 10 10 10 8 8 7 9 9 8 
Seizure score* 3.7a 2.4b 0.5c 2.0b 0.6c 0.3c 1.8b 0.6c O. lc 
Seizure,%# lOQa 9Qa 50b 50b 25b 29b 40b 22b l3c 
BHB, mg/dl 7.lQa 13.2b 23.9C 16. lb 23 .9C 32.2d 19. lb 26.QC 38.ld 
Glucose, mg/dl 113a 89b 44c 77d 61e 50f 90b 73d 63e 
Mg, mg/dl 0.76a 0.67b 0.59C 0.79a 0.72b 0.67C 0.78a 0.58b 0.65C 
Ca, mg/dl 10.sa 7.13d 6.Q2C 10.9a 9.40b 6.83C 9 .29b 9.lOb 8.39C 
P, mg/dl 11.oa 9.31b 7.94c 11.2a 9.81b 7.91C 1 t .4a 9.49b 7.5}C 
K, mg/dl 28.4a 26.2b 27.8a 28.9a 26 .3b 25.7b 29.0a 27 .9a 26.5b 
Na, mg/dl 191a 181C 159C 192a 174e 170f 19la 185b 178d 
-
a,b,c,d,e,f, Values having different superscripts are significantly different (p<0.05). See Appendices A and B, Tables 33 and 
39 for ANOV A and LSD analysis . 
* The higher the score; the more severe the seizures were. 
# The data were analyzed by Chi-square test (see Appendix C, Table 44) . CJ) 
w 
Table 16--The effect of gavaging different BHB doses and different time after dosing 
on audio genie seizure susceptibility (seizure, % ) of weanling rats fed a magnesium-
deficient diet for 17 days (Experiment 3)1. 
BHB, mmoles 
6 4 















4QB 17C 521 
SOB 4QB 571 
(j()B 67D 761 
50b 41b 
I Values having different superscripts are significantly different (p<0.05). See 
Appendix C, Table 45, for Chi-square test. 
Table 17--The effect of gavaging different BHB doses and different time after dosing 



















LOB 0.7B 1.81 
0.8B LOB 1.51 
l.8A l.7A 2.31 
3.6a I.lb 
1 Values having different superscripts are significantly different (p<0.05). See 
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Fig. 8--Effect of gavaging 0.5, 1.0 or 2.0 mmoles of BHB on seizure 
% and seizure score of magnesium-deficient rats tested at 30, 60 or 
120 minutes later (Experiment 3). 
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Table 18--The effect of gavaging different BHB doses and different time after dosing 



















8.30A 43.38 18.41 
5.50A 14.7C 7.52 
4.30A 9.40A 5.02 
6.03a 22.5b 
I Values having different superscripts are significantly different (p<0.05) . See 
Appendices A and B, Tables 34 and 40 for ANOVA and LSD analysis. 
Table 19--The effect of gavaging different BHB doses and different time after dosing 
on serum glucose (mg/dl) of weanling rats fed a magnesium-deficient diet for 17 
days (Experiment 3)1. 
BHB, mmoles 
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l Values having different superscripts are significantly different (p<0.05) . See 
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Serum concentration, mg/di 
Fig. 9--The relationships between serum BHB and glucose vs. percentag of 
seizures and seizure scores of rats fed a magnesium-deficient diet for 17 
days, gavaged with 0.5, 1.0 or 2.0 mmoles of BHB and tested 30, 60 
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Fig. 10--The relationship between serum BHB and glucose of rats fed a 
magnesium-deficient diet for 17 days and then gavaged with BHB 
before seizure testing (Experiment 3). 
70 
71 
Figure 11 illustrates the effects of gavaging various levels of BHB and time-after-
dosing on seizure percentage. There were high correlations between BHB dose and seizure 
percentages, 30 min waiting after dosing, r= 0.98, or 0.99 for 1.0, or 2.0 mmoles BHB, 
respectively, and low correlation with low dose 0.5 mmole of BHB, r= 0.19 (Fig. 11 ). In 
the groups tested 60 or 120 minutes after gavaging BHB, serum glucose level was 
significantly (p<0.05) higher and serum BHB was significantly lower (p<0.05) compared 
with the 30-min levels (Table 19). This was especially true for the 1.0 and 2.0 mmole 
BHB doses. There was a high negative association between time after gavaging BHB and 
serum BHB, r= -0.99, -0.92 or -0.84 for the 30, 60 or 120-min times, respectively (Fig. 
12). In contrast, there was a high positive association between time after gavaging BHB 
and serum glucose, r= 0.93, 0.94, or 0.99 for the 30, 60, or 120-min times, respectively, 
(Fig. 12). 
The serum mineral values were not significantly affected by gavaging BHB. 
However, serum phosphorus was decreased (p<0.05) in some of the groups tested at 60 or 
120 min after dosing due to increased BHB dose and waiting time after dosing (Tables 20 
and 21). 
Experiment four 
In previous experiments; fasting, ketogenic diet and gavaging BHB reduced 
audiogenic seizure susceptibility in magnesium-deficient rats. The purpose of this 
experiment was to determine if audiogenic seizure susceptibility would be increased in 24h-
fasted animals by gavaging glucose 1.4, 2.8 or 5.6 mmoles. Subgroups were tested for 
seizure susceptibility at 30, 60 or 120 min after dosing (Groups 5-13, Table 22). The 
control groups were unfasted sham-gavaged (Group 1) and fasted sham-gavaged (Group 
2). 
All of the unfasted sham-gavaged rats (Group 1) had audiogenic seizures; and 50 
















y =90+0.lx, r= 0.19 1:1 0.5 mmoles BHB 
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Fig. 11--Effect of gavaging various levels of BHB doses and time 
after dosing on seizure % of rats fed a magnesium-deficient diet 
for 17 days (Experiment 3). 
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y =117.0 +6.2x, r=0.93• 0.5 BHB Ser.Glu 
y =93.0 +O. lx, r=0.94 • 1.0 BHB Ser.Glu 
y =71.5 +0.3x, r=0.99 c 2.0 BHB Ser.Glu 
y =4.1-2.5x, r=-0.99 m 0.5 BHB Ser .BHB 
y =8.9 -4.2x, r=-0.92 • 1.0 BHB Ser.BHB 
y =45.9 -0.4x, r=-0 .84 • 2.0 BHB Ser.BHB 
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Minutes after gavaging BHB dose 
Fig. 12--Effect of waiting time after gavaging 0.5, 1 or 2 mmoles BHB on 
serum BHB and glucose of rats fed a magnesium-deficient diet for 17 days 
(Experiment 3). 
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Table 20--The effect of gavaging different BHB doses and different time after dosing 
on serum phosphorus (mgldl) of weanling rats fed a magnesium-deficient diet for 
17 days (Experiment 3)1. 
BHB, mmoles 
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l 1.4B 10.7A 10.91 
10.7AC 10.2BC 10.61 
10.7C 9.81B 10.12 
10.9b 10.2a 
1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 34 and 40 for ANOV A and LSD analysis. 
Table 21--Summary of the effect of gavaging different BHB doses and different time on seizure%, seizure score and serum 
BHB, glucose and mineral concentrations of weanling rats fed a magnesium-deficient diet (Experiment 3). 
Group number 1 2 3 4 5 6 7 8 9 
BHB, mmoles 0.5 0.5 0.5 1 1 1 2 2 2 
Minutes after dosing * 30 60 120 30 60 120 30 60 120 
Number of rats 5 6 5 5 6 5 6 5 6 
Seizure score 3.8a 2.8a 3.4a I.Ob 0.8b 1.8b Q.7C I.Ob 1.7b 
Seizure,%# 1 ()()a 8Qa 1ooa 40b 5Qa 6()a 17c 40b 67a 
BHB, mg/dl 3.5Qa 2.4Qa 1.2oa 8.30ab 5.5oac 4.3Qad 43.3e 14.7b 9.40bcd 
Glucose, mg/dl 118a 122a 124a 95b 102b 106b 8Qb 93b llQc 
Mg, mg/dl 0.52 0.52 0.52 0.57 0.59 0.58 0.56 0.58 0.57 NS 
Ca, mg/dl 6.93 7.05 6.79 6.95 7.08 7.09 7.26 6.93 7.01 NS 
P, mg/dl 10.7a 1Q.9a 9.65b 11.4b 10.7a 10.7a 10.7a 10.2b 9.81b 
K, mg/dl 27.8 27.0 27.2 27.2 27 .7 27.5 27.7 27.2 26 .8 NS 
Na, mg/dl 151 152 151 152 152 151 152 152 152 NS 
a,b,c,d Values having different superscripts are significantly different (p<0.05). See Appendix B, table 17. 
NS Means that treatment "F" was not statistically significant (p< 0.05). 
# The data were analyzed by Chi-square (see Appendix C, Table 22). 
* Minutes after gavaging the BHB . --.J 
lJl 
Table 22--The effect of gavaging n-saline (sham-gavaged), 2.0 mmole B-hydroxybutyrate (BHB) or 1.4, 2.8 or 5.6 mmoles of 
glucose on seizure %, seizure score and serum levels of BHB, glucose and minerals of weanling rats fed a magnesium-
deficient diet for 17 days and fasted O or 24h before dosing (Experiment 4). 
Group number 1 2 3 41 5 6 7 8 9 10 11 12 13 
BHB, mmoles -- -- 2.0 
Glucose, mmoles -- -- -- 1.41 1.4 1.4 1.4 2 .8 2.8 2.8 5.6 5.6 5.6 
Saline,% 0.9 0.9 
Fasting, h 0 24 24 0 24 24 24 24 24 24 24 24 24 
Minutes after dose 30 30 30 30 30 60 120 30 60 120 30 60 120 
Number of rats 8 8 8 8 7 7 6 7 7 6 6 7 6 
Seizure score 1.8a 0.9ac 0.lbc 2.0a 0.4a 0.6ab 1.8bc 1.7abc 1.3ab 2.5bcd 3.Qcde 4.0c 3.5de 
Seizure%# lOQa 50b }4C 86a 43a 57a lOOb 86c 86c l()()c lO()c l()()c 86c 
BHB, mg/dl 0.70a 24.5b 45.lc 0.60a 20.oa 15.la 1.40b 5.50b 5.20b 4.90b 0.90b 0.63b 0.60b 
Glucose, mg/di 91a 44b 79c 111d I 45a 53a 83b 108c 109c 116c 132d 144d 161d 
Mg, mg/dl 0.55 0.56 0.56 0.56 0.55 0.58 0.65 0.55 0 .54 0.53 0.54 0.52 0.53 NS 
Ca, mg/dl 6.87 6.70 7.27 7.06 6.89 6.79 7.22 6.69 6.37 7.24 6.85 7.35 7.04 NS 
P, mg/di 7.34a 7.05a 10.9b 7.24a 7.69a 6.95b 7.13a 6.40b 6.59b 6.87b 6.87b 6.66b 6.35b 
K, mg/dl 26.3a 26.6a 27.8b 26.4a 26.8a 27.0a 28.0a 25.9a 28.4b 28.5b 29.2b 28.7b 28.6b 
Na, mg/dl 155a 155a 152a 155a 160a 158ab 153bc 152cd 154bc 152cd 15Qcd 147d 149cd 
--
a,b,c,d Values in the same row of the same block having different superscripts are significantly different (p<0.05). See 
Appendix B, table 41. 
NS Means that treatment "F" was not statistically significant (p<0.05) . See Appendix A, Tables 35 and 36. 
# The data were analyzed by Chi-square test (see Appendix C, Table 46). ---J a-, 
Table 23--The effect of gavaging n-saline (sham-gavaged), 2.0 mmoles 8-hydroxybutyra 
(BHB) or 1.4 mmoles of glucose on seizure%, seizure score and serum levels of BHB, 
glucose and minerals of weanling rats fed a magnesium-deficient diet for 17 days and 
fasted O or 24h before dosing (Experiment 4). 
Group number 1 2 3 4 
BHB, mmoles 2.0 
Glucose, mmoles 1.4 
Saline,% 0.9 0.9 
Fasting, h 0 24 24 0 
Minutes after dose 30 30 30 30 LSD 
Number of rats 8 8 8 8 8,8 
Seizure score 1.8a 0.9ac O.lbc 2.0a 1.30 
Seizures, % * lOQa 50b 14C 86a 
BHB, mg/dl o.1oa 24.5b 45.lC 0.6Qa 12.9 
Glucose, mg/dl 91a 44b 79C 117d 11.5 
Mg, mg/di 0.55a 0.56a 0.56a 0.56a 0.05 
Ca, mg/di 6.87a 6.70a 7.27b 7.06b 0.40 
P, mg/di 7.34a 7.05a 10.9b 7.24a 0.50 
K, mg/di 26.3a 26.6a 27.8b 26.4a 1.10 
Na, mg/dl 155a 155a 152a 155a 3.40 
a,b,c,d Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 35 and 41 for ANOVA and LSD analysis. 
* The data were analyzed by Chi-square (see Appendix C, Table 46). 
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Serum BHB was 0.7 mg/dl in the unfasted sham-gavaged rats as compared with 
24.5 mg/dl in the sham-gavaged, 24-h fasted rats (Table 23, Groups 1 vs Group 2). In 
contrast, serum glucose was 91 mg/dl in the sham-gavaged, unfasted rats as compared with 
44 mg/dl in the sham-gavaged, 24-h fasted ones (Table 23, Group 1 vs. Group 2). There 
were no significant effects on serum minerals due to fasting. 
Fasting and gavaging with BHB reduced seizure susceptibility (Table 23, Group 
3). Rats that received 2.0 mmoles BHB and were fasted for 24h (Group 3) had decreased 
(p<0.05) seizure score, 0.1, and seizure incidence, 14 percent, compared with sham-
gavaged rats (Group 2); although the reduction in seizure score was not statistically 
significant. The 24-h fasted rats gavaged with 2.0 mmoles BHB (Group 3) had higher 
(p<0.05) serum BHB 45.1 mg/dl, and lower (p<0.05) serum glucose, 79 mg/dl, as 
compared with the fasted, sham-gavaged (Group 2) that had 24.5 and 44.0 mg/dl of BHB 
and glucose, respectively, and as compared with the unfasted sham-gavaged rats (Group 1) 
that had very low BHB, 0.7 mg/dl; and high glucose, 91 mg/dl (Table 23). Rats that 
received 2.0 mmole BHB increased (p<0.05) serum phosphorus compared with rats that 
received saline (Table 23, Group 2 vs. 3). 
Gavaging glucose to unfasted rats did not affect (p>0.05) seizure incidence or 
seizure score (Table 23, Group 1 vs. 4). The unfasted rats that received 1.4 mmoles 
glucose (Group 4) had higher (p<0.05) seizure incidence and seizure score as seizure 
incidence and seizure score in unfasted sham-gavaged rats (Group 1). Serum glucose was 
higher (p<0.05); while serum BHB was not different (p<0.05) from the sham-gavaged rats 
(Group 1). 
The effect of increased serum glucose levels on seizure susceptibility of rats fasted 
for 24-h after being fed a magnesium-deficient diet for 17 days is shown in (Table 22, 
Groups 5-13). The rats were tested for audiogenic seizures 30, 60 or 120 minutes after 
gavaging 1.4, 2.8 or 5.6 mmoles of glucose. Seizure incidence increased (p<0.05) from 43 
percent to 86 percent, to 100 percent in the rats dosed with 1.4, 2.8 or 5.6 mmoles glucose; 
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respectively, and tested 30 min later (Table 24). Consistently, seizure score also increased 
(p<0.05) from 0.4 to 1.7 to 3.0 with glucose dose (Table 25, Groups 5, 8 and 11 in Table 
22). In addition, increasing the testing time after glucose dosing to 120 min increased 
(p<.05) seizure incidence and seizure score at all levels of glucose dosing (Tables 24 and 
25, Groups 7, 10 and 13 in Table 24). Fig. 13 depicts the acute effects of gavaging 
glucose on seizure incidence and seizure score. There were high correlations between 
glucose doses 30 or 60 min after gavaging, and seizure percentages, r= 0.99, or 0.94 for 
1.4 or 2.8 mmoles glucose doses, respectively. There were also high correlations between 
glucose doses 30 or 60 minutes after gavaging, and seizure score, r= 0.97, 0.78 for 1.4 or 
2.8 mmoles glucose doses, respectively (Fig. 13). In contrast, poor correlations were 
found between glucose dose among the groups of rats tested 120 minutes after gavaging 
glucose vs. percent seizure and seizure score, r= 0.0 and 0.33, respectively (Fig. 13). 
Gavaging glucose drastically affected (p<0.05) serum metabolites of the 24-h 
fasted, magnesium-deficient rats (Tables 26 and 27). Serum glucose ranged from 45 to 
161 mg/dl; varying with glucose dose and time of seizure testing (Table 22). In contrast, 
as glucose dose increased, serum BHB decreased (p<0.05); ranging from 20 .0 to 0.6 
mg/dl depending on glucose dose and time of testing (Table 26). As glucose dose was 
increased, serum glucose increased (r= 0.98) and serum BHB decreased (r= -0.99, Fig. 
14) 30 minutes after gavaging. Increasing time after gavaging resulted in higher serum 
glucose concentrations and lower serum BHB concentrations at all levels of glucose 
gavaged (Tables 26 and 27) . For all of the data combined, there was a high negative 
correlation between serum glucose and serum BHB, r= -0.86 (Fig. 15). For all of the data 
combined, animals that seized had low serum BHB and high serum glucose (Appendix D, 
Table 51). 
Serum magnesium and calcium concentrations were not affected in the 24-h fasted 
rats by any of the glucose doses (p>0.05) or time after gavaging (Table 22). There were 
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Table 24--The effect of gavaging different glucose doses and different time after dosing 
on audiogenic seizure susceptibility (seizure, % ) of weanling rats fed a magnesium-





























1 Values having different superscripts are significantly different (p<0.05) . See 
Appendix C, Table 46 for Chi-square test. 
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Table 25--The effect of gavaging different glucose doses and different time after dosing 






























1 Values having different superscripts are significantly different (p<0.05). See 















y=21.4+0.7x, r =0.99 • 1.4 mmoles 
y=78.7+0.2x, r =0.94 r:1 2.8 mmoles 
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y=3.3+0.04x, r =0.33 • 5.6 mmoles • 
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Minutes after gavaging glucose 
Fig. 13--Effect of gavaging 1.4, 2.8 or 5.6 mmoles of glucose on the 
percentage of seizures and seizure scores of rats fed a magnesium-
deficient diet for 17 days and fasted for 24h before dosing 
(Experiment 4 ). 
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Table 26--The effect of gavaging different glucose doses and different time after dosing 
on serum glucose (mg/di) of weanling rats fed a magnesium-deficient diet for 17 days 





























l Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 36 and 41 for ANOVA and LSD analysis. 
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Table 27--The effect of gavaging different glucose doses and different time after dosing 

























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 36 and 41 for ANOVA and LSD analysis. 
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Fig . 14--The effect of gavaging 1.4, 2.8 or 5.6 mmoles of glucose on 
serum BHB and glucose concentrations of rats fed a magnesium-
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Serum BHB, mg/di 
Fig. 15--The relationship between serum BHB and glucose after 
gavaging glucose to rats fed a magnesium-deficient diet for 17 
days and fasted for 24h (Experiment 4). 
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significant increases in the potassium (Table 28) and significant decreases rn the 
phosphorus and sodium by increasing glucose dose (Tables 29 and 30). 
Rats gavaged with 2.8 or 5.6 mmoles glucose (Groups 8 or 11 in Table 22) had 
higher seizure incidence, 86 or 100 percent, as compared with 43 percent seizure in the 24-
h fasted rats given 1.4 mmoles glucose (Group 5) when tested 30 min after gavaging 
(Table 22). Seizure score was also higher (p<0.05); 1.7 or 3.0 (Groups 8 or 11); as 
compared with a score of 0.4 for the rats given 1.4 mmole glucose (Group 5) paralleling 
seizure incidence. 
Fasting clearly decreased percentage of seizures and seizure scores, 43 percent and 
0.4, in the rats gavaged with 1.4 mmole glucose (Group 5); as compared with 86 percent 
seizures and 2.0 seizure score without fasting (Group 4 in Table 22). Similarly, 24-h 
fasted rats given 1.4 mmole glucose (Group 5) had a lower percentage of seizures and 
seizure score than the unfasted sham-gavaged rats (Group 1). Conversely, there was no 
significant difference in seizure incidence and seizure score between rats given 1.4 mmole 
glucose and then sham-gavaged after a 24-h fast (Groups 5 vs. 2 in Table 22). 
Fasting decreased (p<0.05) the serum glucose and increased the serum BHB 
(Group 1 vs. 2). Serum glucose was 117 mg/dl in the unfasted rats given 1.4 mmole 
glucose (Group 4); as compared with 45 mg/dl in the 24-h fasted rats (Group 5), and 
BHB, 0.6 mg/dl, was lower (p<0.05) in the unfasted rats given 1.4 mmoles glucose 
(Group 4); as compared with 20.0 mg/dl in the 24-h fasted rats (Group 5) as shown in 
Table 22. 
Experiment five 
As noted in prior experiments, rats that had high seizure incidence had low serum 
BHB and high glucose. Thus, in this experiment both glucose and BHB were gavaged to 
weanling rats fed a magnesium-deficient diet and fasted for 24h to see if rats with high 
serum levels of both glucose and BHB were susceptible to audiogenic seizures (Table 31). 
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Table 28--The effect of gavaging different glucose doses and different time after dosing 
on serum potassium (mg/dl) of weanling rats fed a magnesium-deficient diet for 17 





























lValues having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 36 and 41 for ANOVA and LSD analysis . 
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Table 29--The effect of gavaging different glucose doses and different time after dosing 
on serum phosphorus (mg/dl) of weanling rats fed a magnesium-deficient diet for 17 





























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 36 and 41 for ANOVA and LSD analysis. 
90 
Table 30--The effect of gavaging different glucose doses and different time after dosing 





























1 Values having different superscripts are significantly different (p<0.05). See 
Appendices A and B, Tables 36 and 41 for ANOVA and LSD analysis. 
Table 31--The effect of gavaging 0, 0.5 or 2.0 mmoles 8-hydroxybutyrate (BHB) and/or 0, 1.4 or 5.6 mmoles of 
glucose in 24h fasted rats fed magnesium-deficient diet for 17 days on seizure%, seizure score and serum BHB, 
glucose and mineral levels (Experiment 5) @. 
Group number l" 2# 3 4 5 6 7 8 
Fasting, h 0 0 24 24 24 24 24 24 
Number of rats 10 9 8 9 10 9 10 9 
BHB, mmoles -- -- 2.0 0 0.5 2.0 0.5 2.0 
Glucose, mmoles -- 5 .6 5.6 5.6 1.4 1.4 
Saline,% .9 LSD 
Seizure score 3.4a 2.4a 0.3b 2.8a 2.9a 2.4a 2. la 1.8a 
Seizure,%• 1ooa 89a 25b 89a 80a 7ga 56c soc 
BHB, mg/dl 0.80a 0.60a 40.6b 0.80 3 1.40a 7.70c 20.6d 20.9d 
Glucose, mg/dl 93a 92a 63b 136c 142c 120d 93a 95a 
Mg, mg/di 0.59 0.57 0.61 0.59 0.58 0.52 0.59 0.59 NS 
Ca, mg/di 5.75 6.42 6.15 6.62 6.45 6.09 6.32 6.04 NS 
P, mg/di 6.44a 6.0la 10.lb 6.69ac 7.2}ad 7.86cde 8.88e 8.78c 
K, mg/di 27.6a 26.8a 24.7b 27. la 26 .Sa 26.8a 27 .3a 26.4a 
Na, mg/di 152 152 151 154 157 154 154 153 NS 
a,b,c,d Values having different superscripts are significantly different (p<0.05) see Appendix B, Table 42. 
NS means that treatment "F" was not statistically significant (p<0.05) see Appendix A, Table 37. 
# Sham-gavaged controls given 0.9 % saline 
" Untreated controls. 
@ The animals were tested for seizures 30 min after gavaging and then blood was drawn 
I.!) 
* The data were analyzed by Chi-square (see Appendix C, Table 47). f-' 
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The effect of gavaging glucose and BHB on seizure incidence, serum BHB, glucose and 
mineral levels of 24-h fasted, magnesium-deficient rats is presented in Table 31. 
Rats gavaged with normal saline did not differ (p>0.05) in seizure susceptibility, 
serum metabolites or serum minerals; as compared with magnesium-deficient rats (Table 
31, Groups 1 vs. 2). Therefore, gavaging has no effect on audiogenic seizure 
susceptibility of unfasted rats. 
Fasted rats gavaged with 2.0 mmole BHB (Group 3) had a lower (p<0.05) seizure 
score, 0.3, and seizure incidence, 25 percent, than unfasted magnesium-deficient rats 
(Groups 1 and 2) that had high seizure scores and seizure incidence, 3.4 and 2.4 and 100 
percent or 89 percent, respectively (Table 31). 
Rats gavaged with 5.6 mmol glucose (Group 4) showed a higher (p<0.05) seizure 
score, 2.8 vs. 0.3, and seizures, 89 percent, vs. 25 percent, compared with rats gavaged 
with 2 mmol BHB (Group 3). Fasted rats gavaged with 5.6 mmoles glucose (Group 4) 
had higher serum glucose (p<0.05), 136 mg/dl, and low serum BHB, 0.8 mg/dl, (Group 4 
vs. 3, Table 31). There was a high positive association between serum glucose and seizure 
percentage or seizure score, r= 0.92 and 0.95; respectively (Fig. 16). There were no 
significant effects on serum Mg, Ca or Na by gavaging 5.6 mmole glucose to fasted, 
magnesium-deficient rats, but the group gavaged with 2.0 mmole BHB had increased 
serum phosphorus and lower serum potassium (Table 31). Fig. 17 shows a high 
association between serum glucose and serum phosphorus, r= -0.98, and a modest 
association between serum glucose vs. serum calcium and potassium, r= 0.61 and 0.65, 
respectively. Fig. 18 shows the negative correlation between serum phosphorus and 
potassium, r= -0.67. In addition, there was a high negative association between serum 
phosphorus and seizure percentage, r= -0.98, and a slightly positive association with 
potassium, r= 0.76 (Fig. 19). 
In Fig. 20, rats given 5.6 mmole glucose and 2 mmol of BHB in the same dose 
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Fig. 16--The relationship between serum glucose and percentage of seizures 
or seizure score after gavaging glucose to rats fed a magnesium-deficient 
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Fig. 17--The relationship between serum glucose and minerals after 
gavaging glucose to rats fed a magnesium-deficient diet for 17 days 
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Fig. 18--The relationship between serum phosphorus (P) and potassium 
(K) after gavaging glucose to rats fed a magnesium -deficient diet for 17 
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Fig. 19--The relationship between serum phosphorus or potassium and 
seizure% after gavaging glucose to rats fed a magnesium-deficient diet 
for 17 days and fasted for 24h (Experiment 5). 
96 
No Treat. 
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Fig. 20--Effect of gavaging 0, 0.5 or 2.0 mmoles BHB and/or 0, 1.4 or 5.6 
mmoles glucose on seizure %, serum glucose and serum BHB levels of rats fed a 
magnesium -deficient diet for 17 days and fasted for 24h. The untreated and sham-
gavaged (0.9% saline) animals were not fasted. The animals were tested for 
seizures 30 min after gavaging and then blood was drawn. (Experiment 5). 
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(Group 3) that had a seizure score of 0.3. In contrast, there was no significant difference 
in seizure score by comparing group 5 with rats given 5.6 mmoles glucose only (Group 4). 
Consistently , rats given 5.6 mmole glucose and 2 mmole BHB in the same dose (Group 5) 
had high seizure incidence, 78 percent, compared with rats given just 2 mmoles BHB 
(Group 3) that had a seizure incidence of 25 percent (Table 31, Fig. 20). In contrast, there 
was no significant difference in seizure incidence by comparing group 5 with rats given 5.6 
mmole glucose (Group 4) only (Table 31, Fig. 20). Rats gavaged with 5.6 mmole glucose 
with 0.5 mmole BHB (Group 6) had a higher (p<.05) seizure score, 2.9, and seizure 
incidence, 80 percent as compared with rats given just 2 mmole BHB (Group 3) that had a 
0.3 seizure score and 25 percent seizure incidence. In contrast, rats given 5.6 mmole 
glucose and 0.5 mmoles BHB (Group 6) showed no significant difference in seizure score 
and seizure incidence ; as compared with rats that received just 5.6 mmole glucose (Group 
5) due to the lowering BHB in the dose. Rats given 1.4 mmole glucose and 2 mmole BHB 
(Group 7) had a 1.8 seizure score and 50 percent seizure incidence; as compared with rats 
given 5.6 mmole glucose (Group 4) and 2 mmole BHB (Group 3) or as compared with rats 
that received 5.6 mmole glucose only (Group 4). Rats given 0.5 mmole BHB and 1.4 
mrnole glucose in the same dose (Group 8) did not have a significantly altered seizure score 
and seizure incidence; as compared with Groups 4, 5, 6, and 7 (Table 31 ). In contrast, 
there was a significant difference in seizure incidence and seizure score between rats that 
received 2 .0 mmole BHB and 1.4 mmole glucose (Group 6) and rats which received 2.0 
mmole BHB alone (Group 3) . Serum metabolites were affected by increasing or 
decreasing the BHB or glucose dosed (Table 31, Fig. 20). Clearly, gavaging high or low 
glucose with high or low BHB in the same dose decreased serum BHB and increased 
serum glucose significantly (Table 31 and Fig. 18). Rats gavaged with 5.6 mmole glucose 
and 2 mmole BHB (Group 5) had decreased (p<0.05) serum BHB and increased (p<0.05) 
serum glucose; as compared with the rats given 1.4 mmole glucose and 2 mmole BHB 
(Group 7). Rats gavaged with 0.5 mmole BHB and 5.6 mmole glucose (Group 6) did not 
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different (p>0.05) serum BHB, while serum glucose was different (p<0.05) as compared 
with the rats given 0.5 mmole BHB and 1.4 mmole glucose (Group 8). 
From the previous comparisons, two conditions appear necessary to prevent seizure 
incidence: 1) high serum BHB and 2) low serum glucose. This conclusion is based on the 
following: 1) Group 8 (Table 31), which was gavaged with high BHB and low glucose, 
had low seizure incidence. 2) Group 5 (Table 31), gavaged with low BHB and high 
glucose, had high seizure incidence. 3) Group 7 (Table 31), gavaged with low BHB and 
low glucose, had medium seizure incidence. 4) Group 5 (Table 31 ), gavaged with high 
BHB and high glucose, had medium seizure incidence. From these observations; high 
serum BHB and high serum glucose were tried as an anticonvulsant but failed due to the 
inhibition of ketone bodies by glucose (Appendix D, Table 52). 
There was a high association between serum concentrations of BHB or glucose and 
seizure percentage in all groups (Fig. 16). Increasing serum BHB to 40 mg/dl by gavaging 
the rats with 2 mmole BHB (Group 3) decreased seizure percentage to 25. In contrast, 
seizure percentage increased drastically to 100 in magnesium-deficient rats (Group 1), 
sham-gavaged rats (Group 2) and in rats given 5.6 mmole glucose (Group 4); which had 
low serum BHB 0.8, 0.6 or 0.8 and high serum glucose, 93, 92 or 136, respectively; (Fig. 
20) and Fig. (16) also show a high positive correlation between serum glucose and percent 
seizures , r = 0.92 . A similar association was found in the rats gavaged with a combination 
of glucose and BHB. Higher serum BHB, 20 .9 mg/dl, was found in rats given 1.4 
mmoles glucose (Group 7) and 2 mmole BHB; which had low seizure incidence, 50 
percent, compared with rats given 5.6 mmole glucose and 0.5 mmole BHB (Group 6) that 





Seizures reportedly happen in rats after 2-7 days on magnesium-deficient diets 
(Chutkow, 1972; Chutkow and Grabow, 1972; Chutkow and Meyers, 1968). However, 
others have reported that seizures did not occur until after 12 days of a magnesium-deficient 
diet (Aikawa, 1973; Buck, et al., 1976; Caddell, 1978). Therefore, the objective of part 
one of the first experiment was to see when magnesium-deficient rats start to seize. Seizure 
susceptibility began after 12 days of feeding the magnesium-deficient diet (Fig. 1 ). In 
addition, the severity of seizures was greatest on day 17 (Table 5). This finding is 
consistent with the findings of Buck et al. (1978) and Caddell (1978) . A number of 
investigators reported lowered magnesium concentrations in serum, cerebrospinal fluid or 
body tissues due to low dietary magnesium. The lowering of magnesium appears first in 
serum, followed by a lowering in cerebrospinal fluid concentrations (Allsop and Pauli, 
1985; Buck et al., 1976; Fisher et al., 1985; Leaver et al., 1987). A sharp decrease in 
serum magnesium, with change occurring in cerebrospinal fluid, is accompanied by a 
marked increase in nervous system hyperexcitability and seizure activity (Bartrop and 
Stone, 1988; Buck et al., 1978; Chutkow, 1974; Leaver et al., 1987). The increase in 
seizure susceptibility after 12d was probably associated with the reduction in CSF 
magnesium occurring at about this time (Buck et al., 1978). 
Handling and gavaging animals might affect audiogenic seizure susceptibility. 
Sham gavaging (saline, 0.9 percent Nacl) of non-fasted, magnesium-deficient rats (Table 
23, Group 1) did not affect seizure incidence because all of the animals had seizures; as 
would be expected of untreated magnesium-deficient rats (Table 23). This gives us 
confidence that handling and gavaging per se did not affect seizure incidence in these 
studies. Differences in caloric density or percentage of the calories from fat might affect 
10 1 
seizure susceptibility. However, no evidence of this was found (Table 15). The effects on 
seizure susceptibility was associated only with the effects of these diets on serum BHB and 
glucose. 
Magnesium effect 
Magnesium-deficient diet clearly induced seizure susceptibility (Tables 5, 15, 22, 
23 and 31); a fact consistent with the findings of other researchers (Anderson et al., 1986; 
Buck et al., 1976, 1978; Chutkow, 1974; Coan and Collingridge, 1985; Kruse et al., 
1932; Leaver et al., 1987; Mahoney et al., 1983). Magnesium deficiency would strongly 
potentiate any subthreshold depolarization; due to either endogenous transmitter release or 
pathological conditions in the central nervous system (CNS). The generation of excitability 
and maintenance of prolonged seizure events (Kruse et al., 1932) are due to the following 
neurological mechanisms: first, enhancement of neuronal excitability to levels that induce 
and maintain abnormal forms of neuronal discharges due to increased ease of transmission 
of field potential across synapses of the central nervous system (Coan and Collingridge, 
1985; Herron et al., 1985). Second, axonal hyperexcitability results from lowered 
depolarization thresholds or resting potential. Both mechanisms cause nerve cells to be 
hypersensitive to stimulation from any source and to be more susceptible to premature 
firing. Physiological concentrations of magnesium ion appear to exert a voltage-dependent 
blockage of the ionophore associated with excitatory amino acid receptors of the N-methyl-
D-aspartate (NMDA) type (Mayer et al., 1984; Nowak et al., 1984). The occurrence of 
spontaneous depolarization in the hippocampus; as well as the stimulated synaptic 
transmission occurring in magnesium-depleted medium; has been explained by removal of 
the blockage (Ascher and Nowak, 1988; Coan and Collingridge, 1985; Herron et al., 
1985). A similar mechanism may be involved in the genesis of paroxysmal events in the 
entorhinal cortex, since both spontaneously occurring and evoked events were blocked by 
NMDA receptor antagonists (Hegstad et al., 1989; Jones and Heinemann, 1988). Thus, 
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the NMDA receptor-mediated excitation is large and prolonged and may also be involved in 
recurrent or feed-forward excitation (Jones and Heinemann, 1988). In addition, reducing 
extracellular magnesium concentration of the medium by bathing a rat hippocampal slice 
preparation reduced ability of adenosine to inhibit the synaptically-evoked propagation 
potential (Bartrup and Stone, 1988). However, other factors; such as a lowered threshold 
for spike generation (McLaughlin et al., 1971) and stimulation of presynaptic transmitter 
release (Herron et al., 1985); contribute to the epileptogenic effect of magnesium ion 
depletion. 
Fasting effect 
Fasting for 24h reduced the susceptibility of magnesium-deficient rats to audiogenic 
seizures (Tables 5, 15, 22, 23 and 31). Hughes and Jabbour (1958), Mahoney et al. 
( 1983) and Peterman (1924) also observed that fasting decreased seizure susceptibility in 
rats. High serum ketone body (BHB) concentrations were observed after 18h or 24h but 
not after 6h or 12h of fasting in magnesium-deficient rats (Table 5). Similarly, reduction in 
seizure incidence did not occur until after 18h of fasting . A significant time-dependency in 
serum was noted because high serum BHB levels did not occur until 18h of fasting (Fig. 
3). In addition, low serum glucose was observed after 18 or 24h but not during the first 
12-h period of fasting (Table 5). During starvation , carbohydrates supply the energy 
required for body function for about 12h; which leads to reduced glucose stores in the 
body. A lack of availability of carbohydrates automatically increases rate of removal of free 
fatty acids from adipose tissues, and in addition, several hormonal responses; such as 
increased secretion of corticotropin, glucocorticoid, glucagon and decreased secretion of 
insulin (Cahill et al., 1966; Efendic et al. 1976; Rodriguez et al., 1984). The lessened 
availability of glucose then initiates a series of events that leads to ketosis. Ketone bodies, 
like BHB, can cross the blood-brain barrier and can be utilized by the brain cells for energy 
(Persson et al., 1972). Fasting experiments in young children (Lacers et al., 1987; London 
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et al., 1986; Sokoloff, 1973) and in rats (Hawkins et al., 1971) demonstrated the tendency 
to develop hypoglycemia and the rapid production and utilization of ketone to spare 
glucose. Fasting increased serum BHB and decreased serum glucose; BHB contributes to 
the energy metabolism of the brain (Bossi et al., 1989; Edmond et al., 1985; Hawkins et 
al., 1971; Krilowicz, 1985; Lacers et al., 1987; London et al., 1986; Peterman, 1946; 
Talbot et al., 1926). Prolonged fasting; both in humans (London et al., 1986; Owen et al., 
1973) and animals (Hawkins et al., 1971; Krilowicz, 1985); results in a striking change in 
metabolism of the brain tissues that acquire the ability to utilize BHB directly as a substrate 
for oxidative metabolism (Edmond et al., 1985; Hawkins et al., 1971; Huttenlocher et al., 
1971; Sokoloff, 1973). This change in brain energy metabolism may well be associated 
with alterations in neuronal excitability in this study. 
A decrease in the blood glucose concentration is associated with increases in ketone 
bodies (BHB) during fasting; which was associated with a diminution or cessation of 
seizure incidence (Tables 5, 15, 22, 23 and 31, Figs . 2 and 3). This finding confirmed 
earlier findings by many investigators (Hughes and Jobbour, 1958; Peterman, 1946; Talbot 
etal., 1926; Wilder, 1921). 
Ketogenic diet (MCT) effect 
Ketogenic diet decreased seizure susceptibility of the magnesium-deficient rats . 
This seems to be due to the ketone production associated with a high MCT diet; which is 
consistent with previous results of the effects of high-fat diet on seizure susceptibility in 
animals (Appleton and DeVivo , 1974; Huttenlocher et al., 1971; Uhlemann and Neims, 
1972). The effect of dietary MCT on seizure incidence may be due to a direct effect of the 
fatty acids contained in MCT; including octanoic and decanoic acid, which has been 
previously demonstrated (Huttenlocher et al., 1971). MCT is rapidly hydrolyzed in the 
gut; and the component fatty acids are readily absorbed. These fatty acids are transported 
to the liver via the hepatic portal circulation as free fatty acids (Greenberger and Skillman, 
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1969; Senior, 1968). These fatty acids are rapidly metabolized by the liver (Pi-Sunyer, 
1971; Senior, 1968). Thus, dietary MCT rapidly induces ketosis. However, Mahoney et 
al. (1983) reported that gavaging MCT did not reduce seizure incidence when the rats were 
tested lh later. This may be due to their methods of treatment, since they gavaged 
magnesium-deficient rats with MCT, as well as the timing of their test lh after gavaging; 
which may have produced ketosis for such a short duration that brain energy metabolism 
remained unaltered and did not effect seizure incidence. Moreover, insufficient data about 
serum ketone bodies may not explain the effect of MCT on seizure incidence. In this 
study, the serum BHB and glucose were measured, and it was found that increasing dietary 
MCT and duration of fasting decreased seizure incidence due to increased serum ketone 
bodies measured as BHB and decreased glucose concentrations (Figs. 5, and 6). This is 
consistent with the effects of ketogenic diet and fasting on epileptic children found by 
Talbot et al. (1927) . The 28 percent MCT diet increased serum BHB dramatically due to 
the inhibition of glucose metabolism in the cell by increasing acetyl Co-A and citrate 
(Jenkins, 1967; Madison et al., 1964; Randle et al., 1964) and decreased serum glucose 
slightly (Table 15, Figs. 5 and 6). This is consistent with the findings of others (Bach et 
al., 1972; Flatt et al., 1985; Guisard et al., 1973; Theuer, 1971). 
Serum metabolites effect 
This study shows that increased serum ketone bodies measured as BHB; decreased 
serum glucose due to a fasting, ketogenic diet (MCT) or gavaging BHB are related to the 
reduction of audiogenic seizure susceptibility in all the experiments. Waiting for 60 or 120 
min after gavaging BHB increased seizure incidence, which is consistent with the findings 
of Mahoney et al. (1983); who found that gavaging MCT did not reduce seizure incidence 
lh later. In addition, this study also shows rats that had low seizure score always had high 
serum BHB and low serum glucose (Appendix D, Tables 48-52). Rats that had not seized 
always had high serum BHB and low serum glucose whether due to increasing in fasting 
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hrs (Table 48, Fig. 2), increasing dietary MCT (Table 49, Fig. 2), gavaging high dose of 
BHB to fed animals (Table 50, Fig. 8) or gavaging low dose of glucose to fasted animals 
(Tables 51 and 52, Figs. 13 and 16). 
In humans, infusion of ketone bodies depresses blood glucose (Jenkins, 1967). In 
animals, ketone-body infusions also depress blood glucose (Bach, et al., 1972; Bossi et 
al., 1989). Madison et al. (1964) demonstrated in dogs that ketone bodies stimulate 
pancreatic insulin release and thus lower plasma FF A and blood glucose. This is consistent 
with this study in which there was always an inverse relationship between serum BHB and 
serum glucose (Figs. 10 and 15). 
Gavaging BHB produces ketonemia and may alter brain energy metabolism even of 
short duration (Huttenlocher et al., 1971). Ketone bodies are the preferred substrate in 
supplying carbon for respiration and lipogenesis in developing brain (Edmond et al., 1985; 
Lacers et al., 1987). Sokoloff (1973) confirmed that the brain can utilize BHB and 
ace toacetate as fuels. A study by Bossi et al. (1989) in dissociated whole-brain cell 
cultures from newborn mice reported the rapid production and utilization of ketone as BHB 
when glucose was lacking. Astrocytes, oligodendrocytes and neurons from developing 
brains all have high capacity to use ketone bodies for respiration (Edmond et al., 1985). 
Hawkins et al. (1971) reported large blood-brain concentration gradients for ketone bodies 
and suggested that relative impermeability of ketone bodies into brain tissue may be a factor 
limiting the rate of their metabolism in brain tissues. Also, obese subjects have induced 
tolerance to hypoglycemia after fasting; and this is associated with increased cerebral uptake 
of BHB and acetoacetate (Owen et al., 1973). 
Elevated ketone concentration that accompanies fasting inhibits glucose oxidation in 
rats (Randle et al., 1964). Metabolism of ketone bodies or free fatty acids increases cellular 
acetyl-CoA concentration. This increase in acetyl-CoA results in an increase in intracellular 
citrate level that inhibits phosphofructokinase activity. Therefore, glucose-6-phosphate 
accumulates within the cell. High glucose-6-phosphate levels inhibits hexokinase that leads 
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to glucose build-up within the cell. This build-up causes decreased glucose uptake by the 
cell (Randle et al., 1964). In this study, increased serum ketone bodies measured as BHB 
were always associated with decreased serum glucose; whether due to fasting, increased 
dietary MCT or gavaging BHB (Tables 5, 8, 9, 15, 18 and 19). The increase in serum 
ketone bodies and the decrease of serum glucose are associated with the reduction of 
seizure susceptibility (Figs. 7 and 9). Ketone bodies like BHB might be used as a source 
of energy for the brain cells; thereby preventing seizures when a low level of glucose is 
available. 
In the first three experiments, serum glucose decreased due to fasting or increasing 
dietary MCT (Tables 5, 15 or 19). This reduction in serum glucose is associated with the 
reduction in seizure incidence (Fig. 9). Therefore, in experiment four, glucose was 
gavaged to fasted magnesium-deficient rats that would normally have a low seizure 
incidence. Gavaging glucose resulted in increased seizure incidence in fasted, magnesium-
deficient rats (Tables 23 and 31); gavaging glucose and testing 30 min after dosing resulted 
in a drastic increase in seizure incidence and seizure score (Table 22, Fig. 13). This result 
confirms the earlier findings by Hughes and Jabbour (1958) and Talbot et al. (1927). 
Also, Mahoney et al. (1983) reported that gavaging glucose did not reduce seizure 
incidence in non-fasted, magnesium-deficient rats that have a high seizure incidence when 
tested lh later. Thus, any ketosis that may have been caused by fasting appears to have 
been depressed by gavaging glucose, thereby allowing seizure susceptibility to recur. 
In all of these observations, rats that had low seizure incidence always had high 
serum BHB and low serum glucose. To try to separate the effects of BHB from glucose, 
the objective of experiment five was to gavage both BHB and glucose simultaneously to 
achieve high serum BHB and glucose; however, it was not possible to get high BHB and 
glucose in the same treatment (Table 31). In all cases, whenever serum BHB was 
increased; serum glucose was decreased. Therefore, it appears that serum BHB has to be 
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at least 20 mg/dl and serum glucose has to be less than 63 mg/dl to reduce audiogenic 
seizure susceptibility in magnesium-deficient rats (Table 5, 15, 22, 23 and 31). 
Seizures and acidosis 
In this study, tonic-clonic seizures caused death of some animals. This may be due 
to a combination of respiratory insufficiency that results from generalized; intense; 
sustained muscular contraction and also from excessive cellular energy needs of the brain 
that may affect functions of the brain tissues. Also, intense muscular activity takes place 
during the seizure, lactic acid accumulates in the plasma; which leads to metabolic 
respiratory acidosis (Howse, 1979). In experimental animals, hypercapnia is sufficient to 
block seizure discharges. The C0 2 accumulation reduces extension to flexion (E/F) ratio of 
mice caused to have maximal electroshock seizures (MES) and increases the latency time 
required for 50 percent of the animals to recover from a first maximal electro-shock seizure 
to have another MES. In contrast, hypoxia increased the E/F ratio and decreased the 
recovery time that lead to enhanced seizures (White et al., 1986). In addition, lactic 
acidosis following prolonged seizures enhances the activity of the Na+JH+ exchanges and 
exaggerates entry of Na+ as well as the coupled influx of Cl- and water. This series of 
events during seizure leads to astrocytic swelling (White et al., 1986). 
Serum minerals and seizures 
A combination of both magnesium deficiency and acute exposure to stressors leads 
to a stimulation of central nervous and neurohumoral mechanisms. The concentration of a 
number of hormones and transmitters is usually elevated, including acetylcholine, gluco-
and mineral corticoids, thyroid and gonadal hormones, vasopressin and catecholamines 
(Classen, 1981; Leaver et al., 1987), which in turn may induce secondary metabolic 
alterations and affect electrolyte metabolism. This alteration may explain the abnormalities 
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in serum mineral concentrations, including calcium, potassium and phosphorus in this 
study. 
Seizure induction is associated with an increase in potassium and sodium and a 
decreas e in calcium and magnesium concentrations in the extracellular space . The drop in 
calcium levels may increase neuronal excitability by decreasing the inhibitory influence of 
potassiurr. afflux (Davies and Peterson, 1989; Lux et al., 1986) . The abnormalities in 
sodium , intassium, calcium and phosphorus may be related to the epileptogenic process. 
One possiJle mechanism for the abnormal electrolyte metabolism in epileptic brain is linked 
to decrea sed (Na +,K+)-ATPase activity (Pedemonte and Beauge, 1986; Rapport et al., 
1975). In hibition of (Na +,K+)-ATPase can lead to membrane depolarization ; resulting in 
stimulat ion of transmitter release (Meyer and Cooper , 1981). Ouabain, a specific inhibitor 
of (Na+ ,K+)-A TPase, results in seizures in rats when injected intraventricullarly into the 
brain (Ch utkow, 1974 ; Rangaraj and Kalant, 1979). The (Na+,K+)-ATPase enzyme acts 
as a trigg er for neurotransmitter release at the synaptic cleft (Hexum , 1977) and for 
maintaini ng the cell's resting potential. Catecholamines may protect against seizures; 
norepinep hrine may act as an endogenous anticonvul sant because decreased norepinephrine 
was assoc iated with reduced (Na+,K+)-ATPase activities (He:xum, 1977) . Thus, decreased 
norepinep hrine conceivably induces convulsions in a normal brain . Gamma-aminobutyric 
acid (GABA), the major inhibitory neurotransmitter ; produces an increase in membrane 
permeability to chloride ions; which increases membrane conductance. When GABA 
contacts membranes that have a specific receptor , chloride ions distribute across the 
membrane due to the chloride equilibrium potential, which is similar to the resting potential 
of the cell. By opening ionic channels, GABA acts on postsynaptic sites like chemical 
voltage clamps, allowing suitable anionic pumping that causes hyperpolarization of the 
excitable membrane to occur. GABA action obviously is a counterbalance to the 
depolarizing influences exerted on cell membranes by passive cation leakage and by the 
excitatory influences (Roberts, 1975). Thus; the increase in serum phosphorus ions may 
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have contributed to decreased seizure incidence seen in this study (Table 31, Fig. 19). In 
addition, calcium in the presence of calmodulin stimulated the release of norepinephrine, 
acetylcholine and acetylcholinesterase from calmodulin-dependent vesicles. This effect of 
calcium on vesicle neurotransmitter release were mediated by calmodulin and required an 
intact biological system that was dependent on magnesium and ATP (DeLorenzo, 1986). 
Therefore, decreased magnesium and calcium in all experiments in this study may decrease 
norepinephrine and acetylcholine; thereby causing seizure susceptibility to be increased; as 
suggested by DeLorenzo (1986) and Heinemann et al. (1986). Except in experiments 2 
and 5, serum calcium was significantly higher in rats fed a 28 percent MCT diet and fasted 
for 24h than rats fed a 3 percent MCT diet (Table 15). This increase in calcium 
concentration is due to a dietary MCT-containing diet that improves the absorption of 
calcium. The improvement in calcium absorption is positively associated with fat 
absorption (Kehayoglou et al., 1968; Tantibhedhyangkul and Hashim, 1978). This 
increase in calcium is associated with the reduction of seizure incidence (Table 15) and 
seizure score (Appendix D, Table 49); in addition, ketosis accompanies fasting and 
increases the dietary MCT effect. This is consistent with the findings of Chaistitwanich et 
al. (1987); Heinemann et al. (1986) and Lux et al. (1986) who found that increasing 
calcium and magnesium concentrations can reduce seizure incidence in animals and in .Yitm 
studies. In experiments 1, 3, 4 and 5, reductions in calcium occurred due to the 
magnesium-deficient diet (Flink, 1985; Fisher et al., 1985; Graber and Schulman, 1986). 
This reduction in calcium level is associated with reduction in seizure incidence (Tables 5, 
21, 22, 23 and 31 ). In contrast, in all experiments increases in calcium level is associated 
with reduction in seizure score (Appendix D, Tables 48-52). However, increased serum 
ketone bodies accompany fasting and gavaging BHB; which may alleviate seizures even 
with low calcium. 
Serum phosphorus and potassium were significantly higher in rats gavaged with 
5.6 mmole glucose as compared with rats that were gavaged with 1.5 mmoles glucose 
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(Experiments 4 and 5, Tables 22, 23 and 31, Fig. 17). There was a negative correlation 
between serum phosphorus and potassium (Fig. 18). In addition, there was a high 
negative correlation between serum phosphorus and seizure incidence (Tables 22 and 23, 
Fig. 19). Consistently, rats that had not seized had high serum phosphorus compared with 
rats that had high seizure score (Appendix D, Tables 51 and 52). Serum potassium was 
increased in the rats gavaged with glucose; and there was a positive correlation between 
serum potassium and seizure incidence (Fig. 19). Consistently, rats that had not seized had 
low serum potassium compared with rats that had high seizure score (Appendix D, Tables 
48-52). This is consistent with the elevated extracellular K+ associated with increased 
neuronal excitability and spread of epileptic activity (Hablitz and Lundervold, 1981; Lux et 
al., 1986); dependent both on the depolarizing effects of K+ accumulation on neuronal 
membranes and on the reduced driving force for K+ outward currents as a result of a 
depolarizing shift of the K+ equilibrium potential (Hablitz and Lundervold, 1981 ). This 
recruitment may be further facilitated through the excitability-increasing effects associated 
with reduction of [Ca+2] concentration (Nicholson, 1980). Elevated K+ concentration has a 
possible significant release of synaptic transmitters from presynaptic terminals because 
afferent impulses arriving in a depolarized terminal would be of abnormally low amplitude. 
However, Cooke and Quastel (1973) found that, at the neuromuscular junction of the frog, 
elevated K+ could cause an increase of acetylcholine release by each motor nerve impulse. 
A moderate elevation of K+ leads to enhancement of excitatory synaptic transmission by 
increasing output of transmitter and by mild depolarization of postsynaptic target cells 
(Somjen et al., 1986). Increased phosphorus concentration increased the inhibitory 
transmitter, especially GABA liberated on dendrites close to a cell body or on an axon 
segment increase permeability to anions, thereby making excitable membranes more 
resistant to depolarization, accelerating the return-to-resting potential of membranes that the 
transmitter contacts (Roberts, 1975). These observations of increased GABA, anions and 
high permeability may explain the decrease of seizure percent to 50, 56 or 25 associated 
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with increases in levels of 8.87, 8.88 or 10.1 mg/dl of serum phosphorus, respectively 
(Table 31, Groups 8, 7, and 2, Fig. 19). 
P-magnetic resonance spectroscopy studies of adult guinea-pig brain tissues 
showed a decrease in phosphocreatine content at 0.2 mM glucose in the superfusing 
medium under normoxia and at 0.5 mM glucose under hypoxia (Cox et al., 1983). 
Insulin-induced hypoglycemia or hypoxic hypoxia induced a decrease in phosphocreatine 
peak coincident with an increase of the inorganic phosphorus peak in the brain of adult 
rabbits. The behavior of the phosphodiester peak in hypoglycemia suggested the 
generation of energy from alternate sources (Prichard et al., 1983). Dissociated whole-
brain cells cultured from newborn mice showed that during glucose deprivation under 
normoxia, D-B-hydroxybutyrate is increasingly used for energy production (Bossi et al., 
1989). These studies are consistent with the present findings that increased serum 
phosphorus associated with gavaging low glucose compared with high dose (Table 22) 
was associated with decreased seizure incidence. As serum BHB increased due to 
decreased glucose metabolism; then seizure incidence decreased. 
Unique associations of serum phosphorus and potassium exist with respect to 
seizure susceptibility (Experiments 1, 2 and 5). At the same time, the changes in serum 
levels of calcium, phosphorus, potassium and sodium were not uniquely associated with 
respect to seizure susceptibility (Experiments 4 and 5). Therefore, fasting, ketogenic diet 
(MCT) and gavaging BHB or glucose did not affect serum minerals in a consistent manner. 
Therefore, the changes in serum minerals do not account for this effect on seizure 
susceptibility. Finally, increases in serum BHB and decreases in serum glucose due to a 
fasting, ketogenic diet (MCT) and gavaging BHB were consistently associated with seizure 
susceptibility of rats fed a magnesium-deficient diet for 17 days. 
CHAPTER IV 
SUMMARY AND CONCLUSIONS 
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From this research, magnesium-deficient diets caused decreased serum magnesium 
concentrations in the first experiment, compared with magnesium-supplemented diet 
(control). Weanling rats fed a magnesium-deficient diet are highly susceptible to 
audiogenic seizures. 
Fasting magnesium-deficient rats for 24h decreased seizure incidence and seizure 
score as compared with unfasted magnesium-deficient rats. 
Fasting increased serum BHB in magnesium-deficient or magnesium-supplemented 
rats; respectively; and decreased serum glucose in magnesium-deficient or magnesium-
supplemented rats, respectively. 
Increasing levels of dietary MCT decreased seizure incidence in weanling rats. 
There was an additive; anticonvulsant effect of fasting plus high dietary level of MCT that 
increased serum BHB and decreased serum glucose; which in tum is related to decreased 
seizure incidence . 
Audiogenic seizure susceptible rats, in general, had lower serum BHB and higher 
serum glucose concentrations than those that did not conivulse due to fasting or dietary 
MCT. 
Changes in the serum levels of magnesium, calcium . phosphorus, potassium and 
sodium were not uniquely associated with seizure susceptibility. But there were significant 
differences in serum levels of these minerals that could modlify the anticonvulsant effects of 
fasting, dietary MCT and gavaging BHB and/or glucose. 
Gavaging BHB decreased seizure incidence, evidence that BHB is associated with 
reduced seizure incidence. 
Serum BHB and glucose were affected significantly due to gavaging BHB. There 
were high negative correlations between serum BHB and glucose concentrations. Serum 
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BHB has to be 20 mg/dl or higher to have an anticonvuilsant effect; in contrast, serum 
glucose has to be 63 mg/ell or higher to have an anticonvuls;ant effect. 
Gavaging glucose to magnesium-deficient rats tha.t were fasted for 24-h increased 
seizure incidence to what would be expected for unfasted irats, evidence that glucose has a 
negative effect on seizure susceptibility . 
Gavaging BHB and glucose simultaneously affecte,d seizure incidence. Increasing 
BHB to 2 mmoles and decreasing glucose to 1.4 mmol1es decreased seizure incidence 
sig nificantly (Table 31) . In contrast , increasing glucose dose to 5.6 mmoles and 
decreasing BHB to 0.5 mmoles in the dose caused seizure incidence to increase 
significantly (Table 31). 
In conclusion: A magnesium-deficient diet is reflected in decreased serum 
magnesium concentrations compared with magnesiu rrn-supplemented diet (control) . 
Weanling rats fed magnesium-deficient diet are highly Sll!sceptible to audiogenic seizure 
compared with magnesium -supplemented rats. 
Fasting magnesium-deficient rats for 24h increased serum BHB and decreased 
serum glucose which is associated with the reduction of sei7zure incidence. 
Increasing level of dietary MCT to 28% decreased seizure incidence due to 
increased serum BHB and decrease serum glucose. 
Gav aging BHB decreased seizure incidence, while gavaging glucose increased 
seizure incidence . 
Audiogenic seizure susceptible rats in general, had lower serum BHB and higher 
serum glucose concentrations than those which did not sei:ze due to fasting, dietary MCT, 
gavaging BHB and glucose. 
Although, some treatments affected serum rniruerals, these effects were not 
consistent among experiments . Therefore, it was concluded that fasting, ketogenic diet 
(MCT), and gavaging BHB and glucose did not affect serum minerals consistently and that 
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modifications in serum minerals caused by these treatments did not account for this effect 




In this study, the relationship between a fasting, ketogenic diet MCT) and 
audiogenic seizure susceptibility revealed that seizures were reduced with increasing 
duration of fasting to 24-h and by increasing the concentration of dietary MCT to 28 
percent. This reduction in seizure incidence by both fasting and dietary MCT was due to 
increased production of ketone bodies (BHB, acetoacetate). Many investigators found that 
most of the organism tissues; even the brain; prefer BHB and acetoacetate as a substrate for 
energy supply. Therefore, determination of serum and cerebrospinal-fluid (CSF) BHB and 
acetoacetate concentrations in relation with seizure susceptibility may be beneficial in the 
interpretations of future experiments. 
Determination of the free fatty acids in serum and cerebrospinal-fluid (CSF) per se 
may be beneficial also as a major factor in limiting ketone-body oxidation. 
Determination of the pH and lactic acidosis after audiogenic seizure susceptibility 
may aid examination of concomitant electrolyte changes. 
Determination of the serum minerals before and after seizure testing may help 
identify the disturbance of minerals during seizure. The affect of bleeding and handling 
animals before seizure testing may affect seizure incidence. 
In all experiments; increased serum BHB and decreased serum glucose increased 
susceptibility to audiogenic seizures of magnesium-deficient rats. Gavaging BHB and 
glucose simultaneously in Experiment (5) confirmed that increasing the glucose to 5.6 
mmoles; even with 2 or 0.5 mmoles of BHB to the rats; increased seizure incidence 
significantly when compared with gavaging BHB alone; which had low seizure incidence 
due to the inhibition of ketone bodies by glucose. Therefore, it will be beneficial to study 
the effect separately and by treating with anti-insulin antibodies to see the effect of those 
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antibodies on the inhibition of insulin and their effect on serum glucose and BHB in 
relation to seizure incidence of magnesium-deficient rats. 
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Table 32--Analysis of variance as tests of significance for effects of magnesium-
deficient diets on seizure score and serum BHB, glucose and minerals 
(Experiment 1, Table 5). 
S.V OF MS F-ratio S-L MS F-ratio S-L 
Glucose BHB 
Treatment 6 2958.7 15.36 0.000 2149.8 6.274 0.000 
Error 32 192.6 342.6 
Seizure score Magnesium 
Treatment 6 8.843 4.675 0.002 1.504 875.00 0.000 
Error 32 1.892 0.002 
Calcium Phosphorus 
Treatment 6 0.575 0.848 0.543 1.866 2.246 0.064 
Error 32 0.678 0.831 
Potassium Sodium 
Treatment 6 83.269 11.382 0.000 101.871 0.984 0.452 
Error 32 7.316 103.514 
S. V = Sourse of variation. 
DF= Degree of fredom. 
MS= Mean of square. 
S-L= Significant level. 
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Table 33--Analysis of variance as tests of significance for the effect of different dietary 
MCT levels and duration of fasting on seizure score and serum BHB, glucose and 
minerals (Experiment 2, Tables 6-15). 
S.V df MS F-ratio S-L MS F-ratio S-L 
Glucose BHB 
MCT (M) 2 2511.85 45.55 0.000 1263.46 33.93 0.000 
Fasting(F) 2 10745.2 194.85 0.000 1933.61 51.93 0.000 
MF 4 1582.8 28.0 0.000 8.537 0.23 0.921 
Error 70 55.14 37.233 
Seizure score Magnesium 
MCT (M) 2 16.079 8.34 0.001 0.024 14.26 0.000 
Fasting(F) 2 31.198 16.18 0.000 0. 159 94 .76 0.000 
MF 4 2.345 1.22 0.312 0.017 10.02 0.007 
Error 70 1.928 0.002 1.928 
Calcium Phosphorus 
MCT (M) 2 15.95 34.74 0.000 0.334 2.19 0.119 
Fasting(F) 2 81.72 178.0 0.000 74 .055 485.6 0.000 
MF 4 6.39 13.9 0.000 0.586 3.842 0.007 
Error 70 0.459 0. 152 0.459 
Potassium Sodium 
MCT (M) 2 3.939 3.497 0.036 429.8 74 .5 0.000 
Fasting(F) 2 37.274 33.09 0.000 3254.7 564.3 0.000 
MF 4 7.327 6.504 0.000 359.4 62.3 0.000 
Error 70 1.127 5.767 1.1265 
S. V = source of variation. 
df= Degree of freedom. 
MS= Mean of square. 
S-L= significant levels. 
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Table 34--Analysis of variance as tests of significance for the effect of gavaging different 
BHB doses at different times on seizure score and serum BHB, glucose and minerals 
(Experiment 3, Tables 16-21). 
S.V df MS F-ratio S-L MS F-ratio S-L 
Glucose BHB 
BHB (B) 2 3091.68 23.6 0.000 1885.3 54.65 0.000 
Waiting time(W) 2 952.84 7.27 0.002 810.57 23.5 0.000 
BW 4 226.38 1.73 0.163 521.88 15.13 0.000 
Error 40 130.98 34.5 130.98 
Seizure score Magnesium 
BHB (B) 2 25.57 9.92 0.000 0.024 5.114 0.011 
Waiting time(W) 2 2.24 0.87 0.427 0.001 0.21 0.811 
BW 4 0.919 0.356 0.838 0.001 0.122 0.974 
Error 40 2.578 0.005 2.578 
Calcium Phosphorus 
BHB (B) 2 0.114 1.114 0.338 2.76 9.576 0.000 
W airing time(W) 2 0.024 0.232 0.794 3.327 11.54 0.000 
BW 4 0. 122 1.183 0.333 0.355 1.231 0.313 
Error 40 0.103 0.288 0.1028 
Potassium Sodium 
BHB (B) 2 0.192 0.12 0.887 1.908 0.993 0.379 
Waiting time(W) 2 0.727 0.456 0.637 1.549 0.806 0.454 
BW 4 0.777 0.488 0.745 0.027 0.014 1.000 
Error 40 1.592 1.921 1.592 
S. V = Sources of variation. 
df= Degree of freedom. 
MS= Mean square. 
S-L= Significant levels. 
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Table 35--Analysis of variance as tests of significance for the effect of gavaging 
n- saline (sham-gavage), BHB or glucose on seizure score and serum BHB, 
glucose and minerals (Experiment 4, Table 23. Groups 1-4). 
S.V df MS F-ratio S-L MS F-ratio S-L 
Glucose BHB 
Treatment 3 7457.6 59.34 0.000 3679.9 23.16 0.000 
Error 28 125.67 158.91 
Seizure score Magnesium 
Treatment 3 5.875 3.481 0.029 0.003 1.037 0.391 
Error 28 1.688 0.002 
Calcium Phosphorus 
Treatment 3 0.489 3.557 0.027 126.819 137.63 0.000 
Error 28 0.137 0.195 
Potassium Sodium 
Treatment 3 4.37 3.635 0.025 14.708 1.304 0.293 
Error 28 1.202 11.277 
S.V= Source of variation . 
df= Degree of freedom. 
MS= Mean of square. 
S-L= Significant levels 
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Table 36--Analysis of variance as tests of significance for the effect of gavaging 1.4, 2.8 
or 5.6 mmoles of glucose at different time on seizure score and serum BHB, glucose and 
minerals (Experiment 4, Tables 22 and 24-30). 
S.V df MS F-ratio S-L MS F-ratio S-L 
Glucose BHB 
Glucose(G) 2 36403 124.3 0.000 652.8 17.95 0.000 
Waiting time(W) 2 3121.6 10.65 0.000 212.09 5.83 0.005 
GW 4 407.5 1.391 0.25 184.63 5.08 0.002 
Error 50 292.95 36.375 292.95 
Seizure score Magnesium 
Glucose (G) 2 32.48 23.16 0.000 0.112 1.629 0.206 
Waiting time(W) 2 4.038 2.88 0.065 0.062 0.904 0.412 
GW 4 1.91 1.362 0.26 0.065 0.949 0.444 
Error 50 1.402 0.069 
Calcium Phosphorus 
Glucose(G) 2 0.474 2.28 0.113 2.88 7.325 0.002 
Waiting time(W) 2 0.76 3.651 0.033 0.443 1.126 0.332 
GW 4 0.617 2.966 0.028 0.695 1.768 0.15 
Error 50 0.208 0.393 0.2081 
Potassium Sodium 
Glucose(G) 2 26.96 15.24 0.000 344.34 15.06 0.000 
Waiting time(W) 2 0.839 0.474 0.625 23.38 1.023 0.367 
GW 4 6.609 3.735 0.01 33.07 1.446 0.233 
Error 50 1.769 22.865 
S.V= Source of variation. 
df = Degree of freedom. 
MS= Mean of square. 
S-L= Significant levels. 
Table 37--Analysis of variance as test of significance for the effect of gavaging BHB and/or 
glucose on seizure score and serum BHB, glucose and minerals (Experiment 5, Table 31). 
S.V df MS F-ratio Sig-level MS F-ratio Sig-level 
Glucose BHB 
Treatment 3 7457.6 59.34 0.000 3679.90 23.16 0.000 
Error 28 125.67 158.91 
Seizure score Magnesium 
Treatment 3 5.875 3.481 0.029 0.003 1.037 0.391 
Error 28 1.688 0.002 
Calcium Phosphorus 
Treatment 3 0.489 3.557 0.027 26.819 137.63 0.000 
Error 28 0.137 0.195 
Potassium Sodium 
Treatment 3 4.37 3.635 0.025 14.708 1.304 0.293 
Error 28 1.202 11.277 
S.V= Source of variation . 
df= Degree of freedom. 







Table 38--Least significant difference analysis 
of the effects of magnesium-deficient diet on 
seizure score and serum BHB, glucose and 
minerals (Experiment 1, Table 5). 
LSD (ni,nj) 
6,6 5,5 6,5 
Seizure score 1.62 1.78 1.70 
BHB (mg/dl) 21.9 23.9 22.9 
Glucose (mg/dl) 16.4 17.9 17.2 
Mg (mg/dl) 0.05 0.05 0.05 
Ca (mg/dl) 0.97 0.97 1.02 
P (mg/dl) 1.75 1.18 1.13 
K (mg/dl) 3.19 3.49 3.34 
Na (mg/dl) 12.0 13.1 12.6 
Table 39--Least significant difference analysis of the effects of dietary MCT level and duration of fasting on seizure score and serum BHB, 
glucose and minerals (Experiment 2, Tables 6-15). 
LSD (ni,nj) LSD (ni,nj) for interaction 
10,9 10,8 10,7 9,8 9,7 8,7 10,10 7,7 8,8 9,9 27,30 27,23 27,26 25,30 25,23 25,26 
Seizure score 1.27 1.31 1.36 1.34 1.39 1.43 1.20 1.50 1.40 1.30 1.60 1.70 1.60 1.60 1.70 1.70 
BHB, mg/dl 5.60 5.60 5.98 5.90 6.10 6.30 5.40 6.50 6.10 5.70 6.90 7.40 7.20 7.10 7.60 7.40 
Glucose, mg/dl 6.79 7.01 7.30 7.20 7.50 7.60 6.60 7.90 7.40 6.97 8.50 9.10 8.80 8.60 9.20 8.90 
Mg, mg/dl 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.05 0.05 0.lu 0.05 0.05 0.05 
Ca, mg/dl 0.62 0.64 0.66 0.66 0.68 0.69 0.60 0.70 0.67 0.64 0.80 0.80 0.80 0.80 0.80 0.80 
P, mg/dl 0.36 0.37 0.38 0.38 0.39 0.40 0.40 0.42 0.38 0.37 0.40 0.50 0.50 0.50 0.50 0.50 
K, mg/dl 0.97 1.00 1.04 1.03 1.06 UJ9 0.94 1.10 1.10 0.99 1.20 1.30 1.30 1.20 1.30 1.30 
Na, mg/dl 2.20 2.3 2.40 2.30 2.40 2.50 2.10 2.60 2.40 2.30 2.70 2.70 2.80 2.80 2.90 2.90 




Table 40--Least significant difference analysis of the effects of gavaging 
different BHB doses on seizure score and serum BHB, glucose and 
minerals (Experiment 3, Tables 16-21). 
LSD (ni,nj) LSD for interaction 
5,5 6,6 5,6 16,16 16,17 
Seizure score 2.10 1.87 1.96 1.2 1.1 
BHB (mg/dl) 7.51 6.90 7.20 4.2 4.1 
Glucose (mg/dl) 14.63 13.40 14.00 8.2 8.1 
Mg (mg/dl) 0 .09 0 .08 0.08 0.001 0 .001 
Ca (mg/dl) 0.40 0.37 0.39 0.23 0.23 
P (mg/dl) 0.69 0.63 0.66 0.38 0.38 
K (mg/dl) 1.60 1.50 1.50 0.9 0.9 
Na (mg/dl) 1.80 1.60 1.70 1.0 1.0 
LSD= Least of significant; where ni is the number of rats in the first 
group and nj the number of rats in the second group. 
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Table 41--Least significant difference analysis of the effects of gavaging 1.4, 2.8 or 5.6 mrnole of glucose on seizure 
score and serum BHB, glucose and minerals (Experiment 4, Tables 22 and 24-30). 
LSD (ni,nj) LSD (ni,nj) for interaction 
6,6 7,7 8,8 6,8 7,6 7,8 18,19 18,20 18,21 19,20 19,21 
Seizure score 1.30 1.3 1.30 1.30 1.3 1.30 0.80 0.80 0.80 0.80 0.80 
BHB(mg/dl) 7.00 17.2 12.90 10.30 6.75 10.50 4.20 4.20 4.20 4.20 4.20 
Glucose (mg/dl) 19.90 18.4 11.5 16.3 19.1 15.40 11.8 11.7 11.6 11.5 11.3 
P (mg/dl) 0.30 0.70 0.50 0.61 0.7 0.60 0.43 0.43 0.43 0.43 0.43 
K (mg/dl) 1.50 1.43 1.10 1.40 1.5 1.30 0.90 0.90 0.90 0.90 0.90 
Na (mg/dl) 5.60 5.10 3.40 4.60 5.3 4.40 3.30 3.30 3.30 3.30 3.30 
LSD= Least significant differences; where ni is the number of rats in the first group and 




Table 42--Least significant difference analysis of the effect of gavaging 
BHB and/or glucose on seizure score and serum BHB, glucose and 
minerals (Experiment 5, Table 31). 
LSD (ni,nj) 
10,10 9, 9 10,9 10,8 9,8 
Seizure score 1.50 1.60 1.50 1.60 1.60 
BHB(mg/dl) 4.80 5.03 5.10 5.1 5.20 
Glucose (mg/dl) 10.50 11.10 10.8 11.2 11.40 
Mg (mg/dl) 0.03 0.03 0.03 0.03 0.03 
Ca (mg/dl) 0.50 0.60 0.6 0.60 0.60 
P (mg/dl) 1.30 1.30 1.3 1.40 1.40 
K (mg/dl) 1.30 1.40 1.4 1.40 1.40 
Na (mg/dl) 3.10 3.98 3.90 4.0Ql 4.10 
LSD= Least significant differences; where ni is the number of rats in 




Table 43--Chi-square test as test of significance for 
seizure% (Experiment 1, Table 5). 
Comparisons x2 sig.-level 
1 VS 2 0.00 NS 
1 VS 3 10.4 s 
1 VS 4 10.8 s 
1 VS 5 7.82 s 
1 VS 6 7.82 s 
1 VS 7 5.00 s 
2 VS 3 10.8 s 
2 VS 4 11.6 s 
2 VS 5 6.21 s 
2 VS 6 7.82 s 
2 VS 7 4.17 s 
3 vs 4 0.00 NS 
3 VS 5 1.34 NS 
3 VS 6 2.00 NS 
3 VS 7 4.00 s 
4 VS 5 2.00 NS 
4 VS 6 2.00 NS 
4 VS 7 4.00 s 
5 VS 6 0.02 NS 
5 VS 7 4.00 s 
6 VS 7 4.00 s 
x2 Chi-square test; where x2, 0.05, 1 =3.84 1. 
1 rat on Mg-supplemented diet and 0-h fasting. 
2 rat on Mg-supplemented diet and 24-h fasting. 
3 rat on Mg-deficient diet and 0-h fasting. 
4 rat on Mg-deficient diet and 6-h fasting. 
5 rat on Mg-deficient diet and 12-h fasting. 
6 rat on Mg-deficient diet and 18-h fasting. 
7 rat on Mg-deficient diet and 24-h fasting. 
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Table 44--Chi-square test as test of significance for 
seizure % (Experiment 2, Tables 7 and 15). 
Comparisons 
1 vs 2 
1 vs 3 
1 vs 4 
1 vs 7 
2 vs 3 
2 vs 5 
2 vs 8 
3 vs 6 
3 vs 9 
4 vs 5 
4 vs 6 
4 vs 7 
5 vs 6 
5 vs 8 
6 vs 9 
7 vs 8 
7 vs 9 
8 vs 9 
1,2,3 vs 4,5,6 
1,2,3 vs 7,8,9 
4,5,6 vs 7,8,9 
1,4,7 vs 2,5,8 
1,4,7 vs 3,6,9 



















































x2 Chi-square test; where x2, 0.05, 1=3.841. 
1 rat on 3% MCT and 0-h fasting. 
2 rat on 3% MCT and 12-h fasting . 
3 rat on 3% MCT and 24-h fasting. 
4 rat on 21 % MCT and 0-h fasting. 
5 rat on 21 % MCT and 12-h fasting. 
6 rat on 21 % MCT and 24-h fasting. 
7 rat on 28% MCT and 0-h fasting. 
8 rat on 28% MCT and 12-h fasting. 
9 rat on 28% MCT and 24-h fasting. 
151 
Table 45--Chi-square test as test of significance 
for seizure % (Experiment 3, Table 16). 
Comparisons x2 sig.-level 
1 vs 2 1.10 NS 
1 vs 3 0.00 NS 
1 vs 4 4.29 S 
1 vs 5 3.29 NS 
1 vs 6 2.50 NS 
1 vs 7 7.82 S 
lvs8 3.71 NS 
1 vs 9 1.99 NS 
2 vs 3 1.30 NS 
2 vs 4 2.28 NS 
2 vs 5 1.50 NS 
2 vs 6 0.66 NS 
2 vs 7 5.33 S 
2 vs 8 2.28 NS 
2 vs 9 0.44 NS 
3 vs 4 4.29 S 
3 vs 5 3.61 NS 
3 vs 6 3.50 NS 
3 vs 7 8.52 S 
3 vs 8 3.14 NS 
3 vs 9 2.61 NS 
4 vs 5 0.13 NS 
4 vs 6 0.03 NS 
4 vs 7 4.66 S 
4 vs 8 0.00 NS 
4 vs 9 0.79 NS 
5 vs 6 0.13 NS 
5 vs 7 1.50 NS 
5 vs 8 0.36 NS 
5 vs 9 0.34 NS 
6 vs 7 2.28 NS 
6 vs 8 2.40 NS 
6 vs 9 0.60 NS 
7 vs 8 0.66 NS 
7 vs 9 3.81 S 
8 vs 9 0.43 NS 
x2 Chi-square test; where x2, 0.05, 1=3.841. 
1 rat on 3% MCT and 0-h fasting. 
2 rat on 3% MCT and 12-h fasting. 
3 rat on 3% MCT and 24-h fasting. 
4 rat on 21 % MCT and 0-h fasting. 
5 rat on 21 % MCT and 12-h fasting. 
6 rat on 21 % MCT and 24-h fasting. 
7 rat on 28% MCT and 0-h fasting. 
8 rat on 28% MCT and 12-h fasting. 
9 rat on 28% MCT and 24-h fasting. 
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Table 46--Chi-square test as test of significance for seizure % 
(Experiment 4, Tables 23 and 24 ). 
Comparisons x2 sig.-level 
1 vs 2 5.30 s 1 VS 3 4.87 s 1 vs 4 12.4 s 2 vs 3 5.82 s 2 VS 4 5.82 s 3 vs 4 9.00 NS 4 VS 5 1.66 s 1 VS 5 6.03 NS 2 VS 5 0.09 s 3 VS 5 5.40 NS 5 VS 6 0.29 NS 5 VS 7 2.90 NS 6 VS 7 3.40 NS 8 VS 9 0.00 NS 8 VS 10 1.08 NS 9 VS 10 1.08 NS 11 vs 12 0.00 NS 11 VS 13 0.00 NS 12 VS 13 0.00 NS 
5,6,7 VS 8,9,lQ VS 11,12,13 9.73 s 
5,8,11 vs 6,9, 12 vs 7,10,13 4.79 s 
x2 Chi-square test; where x2, 0.05, 1==3.841. 
1 rat treated with sham-gavage. 
2 rat treated with sham-gavage and 24-h fasting. 
3 rat treated with 2 mM BHB and 24-h fasting. 
4 rat treated with 5.6 mM BHB without fasting. 
5 rat treated with 1.4 mM glucose; waiting 30 min after dosing. 
6 rat treated with 1.4 mM glucose; waiting 60 min after dosing. 
7 rat treated with 1.4 mM glucose; waiting 120 min after dosing. 
8 rat treated with 2.8 mM glucose; waiting 30 min after dosing . 
9 rat treated with 2.8 mM glucose; waiting 60 min after dosing. 
10 rat treated with 2.8 mM glucose; waiting 120 min after dosing. 
11 rat treated with 5.6 mM glucose; waiting 30 min after dosing. 
12 rat treated with 5.6 mM glucose; waiting 60 min after dosing . 
13 rat treated with 5.6 mM glucose; waiting 120 min after dosing. 
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Table 47--Chi-square test as test of significance for seizure % 
(Experiment 5, Table 31 ). 
Comparisons x2 Sig-level 
3 vs 4 7.150 s 
3 vs 5 3.070 NS 
3 vs 6 5.440 s 
3 vs 7 1.150 NS 
3 vs 8 1.650 NS 
3 vs 2 7.110 s 
3 vs 1 4.970 s 
4 vs 5 1.290 NS 
4 vs 6 0.250 NS 
4 vs 7 3.170 NS 
4 vs 8 2.490 NS 
4 vs 2 0.000 NS 
4 vs 1 1.060 NS 
5 vs 6 0.390 NS 
5 vs 7 0.550 NS 
5 vs 8 0.230 NS 
5 vs 2 1.290 NS 
5 vs 1 2.960 s 
6 vs 7 1.980 NS 
6 vs 8 1.410 NS 
4 vs 2 0.250 NS 
4 vs 1 2.220 NS 
7 vs 8 0.076 NS 
5 vs 2 3.310 NS 
8 vs 2 2.400 NS 
6 vs 1 5.600 s 
2 vs 1 1.056 NS 
1 vs 8 4.090 s 
x2 Chi-square test; where x2, 0.05, 1= 3.841. 
1 animal treated with Mg-deficient diet. 
2 animal treated with 0.9% saline (sham-gavage). 
3 animal treated with 2 mmoles BHB. 
4 animal treated with 5.6 mmoles glucose. 
5 animal treated with 2 mmoles BHB & 5.6 mmoles glucose. 
6 animal treated with 0.5 mmoles BHB & 5.6 mmoles glucose. 
7 animal treated with 2 mmoles BHB & 1.4 mmoles glucose. 




Table 48--The relationship between seizure score vs. serum BHB, glucose and minerals (mg/dl) of magnesium-deficient rats 
(Experiment 1 ). 
Fasting, h 0 6 12 18 24 
Seiz. score 1 3 4 1 2 4 0 1 4 0 1 0 1 2 4 
No. of rats 2 1 3 2 1 3 1 3 1 1 5 3 1 1 1 
BHB 5.2 2.1 2.1 14.6 12.5 5.9 18.7 18.0 11.4 96.7 22.7 70.2 62.4 30.1 18.7 
Glucose 72 67 112 73 78 76 56 59 69 42 47 31 33 33 29 
Mg 0.68 0.56 0.53 0.61 0.61 0 .53 0.56 0.58 0.58 0.56 0.57 0.58 0.58 0.53 0.53 
Ca 7.3 6.9 6.8 7.3 6.5 6. 8 7.7 6.6 6.5 6.9 6.1 6.9 6.4 5.2 5.2 
p 7.0 5.3 5.8 6.8 7.1 Si.9 6.4 5.3 3.9 7 .6 6.5 7.4 7 .6 6.6 5.6 
K 25.7 26.2 28.3 25.1 26.2 2 5.5 27.5 28.7 29.8 23.5 26.4 25.2 26.4 27.5 27.5 




Table 49--The relationship between seizure score vs. serum BHB, glucose and minerals (mg/di) of magnesium-
deficient rats fed 3, 21 or 28 percent MCT and fasted 0, 12 or 24h before testing (Experiment 2). 
MCT,% 3 21 
Fasting, h 0 12 24 0 12 24 
Seiz. score 1 4 0 1 4 0 1 0 4 0 1 4 0 
No. of rats 1 9 1 4 5 5 5 4 4 6 1 1 5 
BHB 9.40 6.80 15.6 14.3 11.9 32.2 15.6 18.7 13.5 24.8 22.9 13.5 35.9 
Glucose 117 113 97 92 85 31 57 82 72 64 62 48 54 
Mg 0 .80 0.76 0.72 0.66 0 .67 0.59 0.61 0.85 0.75 0.75 0.64 0.61 0.68 
Ca 11.1 10.5 7.29 7 .39 6.8'9 6.11 5.73 10.8 10.8 9.57 9.60 8.13 6.97 
p 11.4 10.9 9.30 9.38 9.2 t5 8.04 7.83 11.3 11.1 10.1 9.40 8.30 8.36 
K 27.5 28.5 25.5 26.0 26.5 26.8 28.8 28.7 29.3 26.2 27.5 26 .2 25.8 















Fasting, h 0 
Seiz. score 1 4 0 
No. of rats 1 9 1 
BHB 22.7 14.6 28.1 
Glucose 94 85 75 
Mg 0.81 0.75 0.56 
Ca 10.6 10.0 9 .39 
p 11.4 11.5 9 .50 
K 28.7 29 .5 27.8 







0 .70 0.55 
8.10 8.10 
9.-40 9.20 
























Table 50--The relationship between seizure score vs. serum BHB, glucose and minerals (mg/di) of magnesium- deficient rats 
gavaged with 0.5, 1.0 or 2.0 mmoles of BHB and tested at 30, 60 or 120 min after gavaging (Experiment 3). 
BHB,mM 0.5 1.0 
Tested, min 30 60 120 30 60 120 
Seiz. score 3 4 0 1 4 I 4 0 I 4 0 I 3 0 1 
No. of rats 1 4 1 I 4 I 4 3 1 I 3 2 I 2 1 
BHB 3.1 3.6 2.1 2.6 2.5 1.0 1.3 8.7 9.4 6.2 5.7 5.5 5.2 4.2 4.6 
Glucose 109 120 109 112 126 118 124 94 95 99 101 100 113 103 105 
Mg 0.56 0.51 0.58 0.56 0.50 0.516 0.51 0.60 0.50 0.56 0.64 0 .56 0.50 0.68 0.56 
Ca 7.33 6.83 i.32 , .31 6.91 i.31 6.66 7.04 7.02 6.63 7.24 6.90 6.91 7 .37 7.31 
p 11.2 10.5 10.8 11.04 10.8 9.32 9.73 11.5 11.2 11.2 10.6 10.9 10.4 10.1 10.8 
K 26.2 28.3 25.2 25.2 27.9 25.2 27.7 27.1 27 .5 28.7 27.0 28.1 28.7 26.2 27.5 















Tested min 30 
Seiz. score 0 4 0 
No. of rats 5 1 3 
BHB 79.0 17.7 16.3 
Glucose 48 85 78 
Mg 0.58 0.50 0 .62 
Ca 7.33 6.91 7.20 
p 10.9 9.52 10.7 
K 27.5 28.7 26.3 
Na 152 153 151 
2.0 
60 
1 4 0 
1 1 2 
12.5 12.0 10.3 
115 116 85 
0.53 0.50 0.66 
6.51 6.52 7.16 
9.52 9.33 10.6 
28.5 28.7 25.5 























Table 51--The relationship between seizure score vs. serum BHB, glucose and minerals (mg/di) of magnesium- deficient rats 
gavaged with 1.4, 2.8 or 5.6 mmoles glucose and tested 30, 60 or 120 min after gavaging (Experiment 4). 
Glucose,mM 1.4 2.8 
Tested min 30 60 120 30 60 120 
Seiz. score 0 1 0 1 1 3 4 0 1 4 0 1 4 1 4 
No. of rats 4 3 3 4 4 1 1 1 4 2 1 5 1 3 3 
BHB 29.7 7 .20 28.9 7 .50 1.60 1.60 0.80 16.1 5.30 0 .83 6.80 5.70 1.00 6.10 3.70 
Glucose 42 49 45 59 77.4 96 90 75 109 123 99 109 120 110 122 
Mg 0.61 0.54 0 .60 0.54 0.55 0.56 0.53 0.58 0.53 0.52 0.58 0.54 0.50 0.54 0 .51 
Ca 7.23 6.44 7.20 6.49 7.26 7.3 0 7.01 7 .70 6.59 6.41 7.30 6.35 5.54 7.40 7.04 
p 7.75 7.60 7.40 6.60 7_gQ S,JjO 5.60 7.60 6.50 5.60 7.60 6.60 5.50 6.90 6.63 
K 26.2 27.5 26.3 27.6 25.9 26.2 26.2 24.6 25.4 27.5 23.5 26.6 28.7 27.1 29.8 






Tested min 30 
Seiz. score 1 4 
No. of rats 2 4 
BHB 1.60 0.55 
Glucose 126 133 
Mg 0.56 0.52 
Ca 7.16 6.49 
p 7.10 6.70 
K 28.1 29.4 
























Table 52--The relationship between seizure score vs. serum BHB, glucose and minerals (mg/dl) of 
magnesium-deficient rats gavaged with 0.5 or 2.0 mmoles of BHB and/or 1.4 or 5.6 mmoles of 
glucose and tested 30 min after gavaging (Experiment 5). 
Glucose,mM 5.6 5.6 1.4 1.4 
BHB,mM 2.0 0.5 2.0 0.5 
Seiz. score 0 3 4 0 3 4 0 1 4 0 3 4 
No. of rats 1 1 4 2 3 5 5 1 4 4 2 3 
BHB 17.6 10.5 3.90 3.00 1.10 0.80 27.6 14.6 14.1 21.7 21.0 16.5 
Glucose 100 99 130 121 143 151 83 107 108 85 88 106 
Mg 0.66 0.60 0.55 0.66 0.56 0.56 0.62 0.58 0.56 0.63 0.58 0.56 
Ca 6.70 6.60 5.28 7.60 6.27 6.10 6.64 6.00 5.50 6.18 6.15 6.63 
p 9.50 9.30 7.10 9.40 7.40 6.22 10.6 9.50 6.33 10.8 8.45 6.87 
K 22.5 25.5 28.1 25.1 26.8 26.9 25.2 28.7 27.4 26.5 28.1 27.9 
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